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I.  INTRODUCTION 
1.  BACKGROUND. 
In its com.munication of 24 November 1993 on the framework for action in the field of public 
health<
1> the Commission defined a framework for Community action in order to attain the 
objectives on health protection laid down in Articles 3(  o) and 129 of the Treaty establishing 
the European Community. The role of  the Community is identified as underpinning the efforts 
of  the  Member  States  in  the  public  health  field,  assisting  in  the  formulation  and 
implementation  of objectives  and  strategies,  and  contributing  to  the  provision  of health 
protection across the Community,  setting as  a target the best results  already  obtained in  a 
given area anywhere in the Community. 
In initiating action  under Article  129,  the  Community  has to address  itself to preventing 
disease  and  protecting  health .. Based  on  the  criteria  laid  down  in  the  Commission 
communication, AIDS and other communicable diseases have been identified as a priority for 
Community action. 
/ 
These are diseases which have the following characteristics: 
they cause or are likely to cause in the absence ,¢'. intervention, significant premature 
death and/or overall high death rates;  r 
they cause or are likely to cause in  the absence of intervention,  significant ill health 
incluqing high morbidity and/or disability; 
they have significant implications for the quality oflife as well as major socio-economic 
effects, such as high health care and treatment costs, and considerable absenteeism and 
unfitness for work; 
and for whi((h: 
practicable measures_ of prevention exist; 
there  would  be  added  value  from  the  Community· undertaking  actions,  particularly 
through economies of scale. 
4.  Furthermore,  AIDS  has  been  singled  out  by  the  Council,  the  European  Parliament,  the 
Economic and  Social  Committee,  and  the  Comrp.ittee  of the Regions,  as  a major  scourge 
which deserves special attention by the Community. A long series of resolutions, conclusions 
and  opinions by  these institutions  culminated  in  June  1994  in the adoption  of a common 
. position<
2> by the Council, following favourable opinions by the other bodies, concerning the 
prolongation in 1994-1995 of  the "Europe against AIDS" programme along the lines proposed 
by the Commission. 
(1) 
(2) 
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5 5.  The AIDS crisis has aroused interest, from  the public health point of view,  in all  the other 
dise~ses in this category.  This applies  first  and  foremost to the other sexually  transmitted 
diseases  (STDs)  which·. can· often  accompany  the  IllV (human  immunodeficiency  virus) 
infection which leads to AIDS. The occurrence of certain STDs alongside IllV infection has 
caused the infectious disease experts to re-think many of their ideas, obliging them to adapt 
to a new, complex and constantly evolving reality. The renewed interest applies also to those 
infectious diseases  which  accompany the onset of AIDS  proper,  and  which  are known  as 
opportunistic infections. Some of these, which have been known about for a very long time, 
now need to be monitored more vigilantly, such as for example tuberculosis. 
2.  BASIC CHARACTERISTICS OF  COMMUNICABLE DISEASE$ 
6.  At various stages in our history there have been epidemics which have affected and even 
decimated whole populations.  The plague of the Middle Ages wiped  out a quarter of the 
population of  western Europe in a mere four years, and the Spanish flu, which ravaged every 
continent at the start of  this century, killed more than 20 million people in the space of a few 
months. But medical advances such as the development of  vaccines and new drugs, combined 
with  substantial  improvements in  living conditions  and  public hygiene,  have  considerably 
reduced the threat from infectious diseases to the citizens of  the European Union. Worldwide, 
however,  infectious diseases  are  still  a  major  cause  of death,  and  in the least-developed 
countries they represent more than 70% of the global burden of disease. 
7.  A remarkable success has recently been achieved in the fight against communicable disease 
by the eradication of smallpox. Through a combination of active monitoring and an effective, 
easy-to-use vaccine, the health authorities managed first to stem the spread of the smallpox 
virus and then cause it to disappear attogether, thus eradicating this disease from the surface 
of the Earth.  In the same period,  however,  infectious diseases which were thought to have 
disappeared or to be on the  way  out have  begtin to re-appear,  and have reached epidemic 
proportions in certain places. 
8.  Examples are diphtheria,  which is rampant again in eastern Europe, and, to a lesser degree, 
poliomyelitis,  which  was  thought  to  be  on  the  point of extinction.  Another  example  is 
tuberculosis,  the  resurgence  of which  results  from  a  combination  of factqrs,  such  as  the 
slackening of  vaccination programmes, the inability of  certain drugs to cope with resistant new 
strains,  and poor living conditions - all factors about which something could be  don~. 
9.  Moreover,  new  diseases  are  appearing  on  the  s'cene,  ranging  from  Lyme  borreliosis, 
transmitted  by  ticks  and  becoming  increasingly  prevalent,  to  chlamydiosis,  a  sexually 
transmitted bacterial disease which has serious implications for female fertility. 
6 (2) 
10.  Of particular  importance  has  been  the  appearance  of IDV  infection,  which  has  become 
pandemic since its appearance at the start of  the 1980s and which leads to AIDS. It has rightly 
given great cause for concern because it is fatal  in the long term and because there is at yet 
no serum, vaccine or effective treatment available.  Its nature is such that it has forced the 
public authorities to take measures guided by the circumstances to try to halt its progression 
and this explains why so much attention is being paid to it. If  the weapons deployed· so far 
against it appear ineffective, there can  be no doubt that they have nonetheless borne some 
fruit, both in terms of checking somewhat its spread in certain countries and among particular 
groups, and also in terms of the beneficial impact they have had on the fight against sexually 
transmitted diseases in general. 
11.  All communicable diseases are caused by  a transmissible agent, such as a bacterium, a virus, 
a parasite, a worm or a fungus. To combat these infectious diseases  as effectively as possible, 
it is therefore necessary to find ways of preventing these agents from causing disease. 
12.  The modes of transmission of irifectious  agents  include:  water (cholera,  hepatitis A,  etc.); 
animals  which  transmit various  zoonoses  to  man  (brucellosis,  trichinosis,  echinococcosis, 
rabies, tuberculosis, etc.); food (salmonellosis, listeriosis, etc.); the environment (legionellosis, 
etc.);  human ,contact (tuberculosis, influenza,  etc.);  the iatrogenic route (blood transfusions 
which can tninsmit the IDV virus, the hepatitis C virus, etc.). 
13.  A distinction needs to be made between infection, i.e. the fact that one of these agents takes 
up residence in the body of  an individual and multiplies within it, very often with no obvious 
clinical manifestations, and the disease itself, i.e.  it produces symptoms and signs which, in 
most cases, is the only aspect which the general public worries about. Many more people carry 
an infection, all too often without realising it,  or are exposed to a source of infection, than 
actually  contract  a  disease  and  become  ill.  Controlling  or  reducing  the  spread  of any 
communicable disease is usually restricted to measures aimed at containing the transmission 
of the infectionby the causal agent. For example, chronic carriers of the hepatitis B vi~s or 
·the IDV virus are not necessarily ill but m(ly,  in certain circumstances, transmit the infection 
to other unaffected persons. In this respect, such carriers are a potential risk to public health. 
14.  The severity of a communicable disease depends not only on the intrinsic danger constituted 
by the causal agent but also on whether it is able or not to spread easily in the environment 
and at some stage to affect the state of health of any  individual contracting it.  Furthermore, 
in the case of some communicable diseases the infection process is due to toxins produced by 
the causal agents.  This is the case with the agents responsible for botulism and tetanus,  for 
example. Finally, certain agents responsible for communicable diseases are able to trigger an 
allergic process within man, such as Ascaris Suum and Candida Albicans. 
15.  Communicable diseases may affect the general population, or be more prevalent in certain risk 
groups or in some types of situations. A distinction is therefore made between the following: 
communicable diseases affecting the general  public,  such as IDV, hepatitis (A,  B and 
C  espeeially),  tuberculosis,  sexually  transmitted  diseases,  gastrointestinal  diseases, 
communicable  diseases  (other  than  tuberculosis  and  hepatitis)  preventable  through 
vaccination, and zoonoses; 
7 those affecting,  more particularly,  certain  categories of the population classifiable as 
being "at-risk"; these communicable diseases can become dangerous when they affect 
certain constitutionally or physiologically fragile categories of the population: 
Among  pregnant  women  these  are  rubella  (German  measles),  toxoplasmosis, 
listeriosis and rickettsioses. 
Among children these are diseases which can be tackled through vaccination such 
as diphtheria, whooping cough, poliomyelitis and tuberculosis, but also hyperacute 
communicable diseases which have an adverse effect on survival prognosis (such 
as certain meningococcal infections). 
Among old people this is influenza,  which - although preventable, in particular 
. through vaccination - can  assume  serious  dimensions,  thus  adv~rsely affecting 
survival prognosis. 
Among fragile individuals, such as the immunodepressed, alcoholics, the disabled, 
but  also  excluded  individuals  living  in  adverse  or  precarious  socio-economic 
conditions,  often far below the poverty line,  such  as  the homeless or migrant 
communities, certain mycotic or parasitic infections, anaerobic germ infections and 
opportunistic infections. 
And, finally, those whose transmissibility is increased in certain situations: 
this is particularly the case for hospitals where nosocomial infections are causing 
an increasing prevention problem; 
in  communities  (nurseries,  armed  forces,  holiday  camps,  schools)  where 
gastrointestinal diseases, hepatitis and infections preventable through vaccination 
are occurring more and more often; 
in  prisons,  where  there  is  a  clear  rise  in  the number  of sexually  transmitted 
diseases and HIV infection. 
3.  SELECTION OF CERTAIN COMMUNICABLE DISEASES FOR  COMMUNITY 
ACTIONS 
16.  In this  Communication the Commission  sets  out the measures it proposes to undertake to 
prevent communicable diseases,  drawing on the knowledge and experience acquired in the 
course of  its previous actions. The Community cannot tackle all communicable diseases in one 
go since there are so many of them. Nor is it possible to cover all communicable diseases in 
this Communication, since there are far too many of them and their repercussions on public 
health are so variable. 
8 17.  In view of the limited resources available to the Community,  a  selection  has to be made 
among the communicable diseases in order to identify those which would be the object of 
action yielding the highest Community added value;  moreover,  preference will  have to be 
given to actions which can also benefit the fight against the greatest possible number of such 
diseases.  Community  actions  must  primarily  encourage  cooperation between the Member 
States,  and aim, where appropriate,  at coordinating health policies and programmes.  In this 
context, the fact,  for example, ·ihat many  communicable diseases can be treated effectively 
with chemotherapy or can be contained through tried-and-tested vaccination programmes has 
been followed up more assiduously by some Member States than by others,  and has thus 
resulted in a widely contrasting situation which merits closer, case-by-case analysis. Finally, 
the communicable diseases to be selected must include those for which the Member States 
themselves and the Community institutions  have expressed an interest or preference for  a 
contribution by the Community primarily on the basis of  the perceived risks to individuals as 
well as to the society as a whole. 
18.  Applying this approach to communicable diseases involves selecting those diseases which are 
to be the main focus of this action, viz.: 
1.  lllV infection, AIDS and sexually transmitted diseases; 
2.  diseases which can be prevented through vaccination; and 
3.  diseases which can be tackled through certain specific Community measures. 
II.  THE  SITUATION  AS  REGARDS  COMMUNICABLE  , DISEASES  AT 
COMMUNITY LEVEL 
1.  ZOONOSIS 
19.  Zoonoses, i.e. infectious diseases carried by animals and liable to be transmitted to man, have 
been  the  subject  of close  attention  for  more  than  three  decades.  The  Community  has 
endeavoured. to  contribute  to  safeguarding  public  health  in ·general  by  adopting  and 
implementing a series of specific programmes involving substantial funds (for instance, over 
MECU  125  for  the  1987-1992  period)  and  aimed  at  combatting  or eradicating  certain 
zoonoses. 
20.  Since 1964 Community programmes have focused on monitoring and eradication of bovine 
tuberculosis, as a result of which many herds in the Community have been declared clear of 
this disease. The same applies to bovine brucellosis (B. abortus) and, more recently, sheep and 
goat brucellosis, while the fight against B.  melitensis continues. Since 1989 the battle against 
rabies, in wild animals especially, has made good progress thanks to vaccination by means of 
aerial dropping of  bait. Trichinosis is now under better control thanks to improved processing 
of  fresh meat, especially horse meat. As for salmonellosis, this has received special attention -
over and  above that stipulated by legislation - including efforts to improve the quality  of 
livestock,  hygiene  in  abattoirs  and  undertakings  processing  and  transforming  products  of 
animal origin into foods for human consumption. In this respect, significant progress has been 
achieved through the establishment of  microbiological criteria designed to ensure the absence 
of  salmonella or related contaminants, plus checks on application thereof in the case of  minced 
meat, meat-based products, shellfish, milk and egg products. 
9 2.  IDV INFECTION, AIDS AND  SEXUALLY TRANSMITTED DISEASES 
21.  By  31  March  1994,  a cumulative total  of 105 446  AIDS  cases,  including  1 920 paediatric 
cases, had been reported in the twelve countries of the European Community (EC) and 6 476 
(including 6 386 adults/adolescents and 86 paediatric cases) in the six COST<
3> countries. The 
cumulative number of cases reported by cougtry ranges from 79 in Luxembourg to 30 003  in 
France.  Three  countries  (France,  Italy,  and  Spain)  have  reported  over 20 000  cases  and 
account  for  72%  of the  cases  reported  in  the  EC.  In 1993  over  20 000  new  cases  were 
reported, and 6 000 for the first three months of 1994. 
22.  The analysis of adult/adolescent cases by  transmission group from  1990 to  1993  shows an 
increase in the proportion of cases attributed to heterosexual contact (from 10.8% to 15.3%) 
and among intravenoos drug users (IDUs) (from 40.0% to 41.8%). In the same period, there 
were gradual decreases in the proportions of homo/bisexual males (from 39.3% to 32.2%), 
haemophiliacs (from  1.7% to  1.1%) and transfusion recipients (from 2.2% to 1.5%). 
23.  A  preliminary  breakdown of the  transmission  category  "heterosexual  contact"  shows  an 
increase, from 1990 to 1993, in the proportion of cases in several groups: persons originating 
from  countries  where  heterosexual  transmission  is  common  (from  2.9%  to  3.7%  of all 
adult/adolescent cases), persons with an IDU partner (from 2.5% to 3.5%), and persons with 
an IDV-positive partner without a known risk factor (from 1.2% to 2.9%). 
24.  The proportion of infected females is 15.2% among adult/adolescent cases but 46.7% among 
paediatric  cases.  This  proportion  varies  according  to  the  transmission  group:  c  among 
adult/adolescent cases, it is highest in the transfusion recipient group ( 46.1% females) and in 
the heterosexual  contact group  (43.0%  females).  Among cases in  the heterosexual  contact 
group, 67.0% ofpersons with an IDU partner are females. 
25.  The analysis of cases by period of diagnosis,  from  1990 to 1993,  shows an increase in the 
proportion of females among adult/adolescent cases (from 14.9% to 18.3%). This increase is 
largely correlated to the decrease in the proportion of homo/bisexual cases, but also reflects 
an  increase (from 40.8% to 45.4%) in  the  proportion  of female cases in  the  heterosexual 
contact group.  This latter increase is  observed  particularly among persons originating from 
countries where heterosexual transmission is common (36.8% to 46.0%) and  among persons 
with an IDU partner (61.9% to 68.4%). 
26.  The total number of people in the Community infected with HIV is unknown.  Nevertheless, 
application of certain mathematical models makes it possible to estimate the number of people 
who are currently seropositive - at  something in the region of half a million throughout the 
Community, with major variations from  one country to another. Thus, there are thought to be 
some 200 000  seropositives in France and under 50 000 in the United Kingdom.  If,  as the 
present state of knowledge indicates, all seropositive individuals eventually develop full-blown 
AIDS, this provides some idea of the extent of the public  h~alth problem faced,  all the more 
so given that prevention by vaccination or effective chemotherapy are not yet possible. 
(3)  Cooperation in Scientific and Technical Research. 
10 27.  In each Community country one or more national surveillance systems cover certain sexually 
transmitted diseases: gonorrhoea and syphilis are monitored in all Member States, but this is 
not so for genital herpes. Furthermore, case definitions vary from one Member State to another 
.depending  on  the  type  of disease  monitored.  This  means  that  given  the  relatively  low 
prevalence of the most common sexually transmitted diseases - such as, gonorrhoea, syphilis, 
chlamydiosis, Condylomata A infection, genital herpes, soft chancre, granuloma inguinale and 
lymphogranuloma  venereum  - we  currently  have  no  accurate  epidemiological  data  at 
Community level. 
3.  COMMUNICABLE DISEASES PREVENTABLE BY VACCINATION 
28.  Many  communicable  diseases  can  be  contained  through  tried-and-tested  vaccination 
programmes. Public health programmes to eliminate certain communicable infectious diseases 
have often based themselves on vaccination, which is the most effective means of prevention 
for many of them.  However, the resurgence of certain communicable diseases lends weight 
to the need for a re-examination. of vaccination policies used by Member States to assist in 
improving their control. 
29.  Vaccination policies may differ in their aims, from eradication to elimination or to control of 
the disease.  Eradication means bringing about the total  and definitive disappearance of the 
causal  agent and  the disease,  but it can:  only  be successful  if there is a global  strategy  at 
international level.  Elimination means bringing about a situation in which the causal agent 
continues to exist but the incidence of the disease is extremely low;  this is costly for the 
public  health  sector,  since  it involves  regular  and  long-term  expenditure. on  vaccination 
programmes, permanent monitoring, and intervention whenever an epidemic flares up. On the 
other hand, control aims merely to bring about a situation where the existence of the disease 
does not constitute a major health problem: the vaccination policy is directed towards certain 
groups of the population considered to be at high risk. 
30.  Member States' vaccination policies differ,  ranging between compulsory vaccination, either 
for everyone or for certain groups, and voluntary vaccination, with or without incentives such 
as  free  vaccines.  The  countries  with  the  most  similar  vaccination  P.Olicies  are  France, 
Luxembourg and the United Kingdom. All Member States vaccinate against diphtheria, tetanus 
and poliomyelitis, and most vaccinate against whooping cough, measles, mumps and rubella. 
Increasingly vaccination is also offered against haemophilus influenza B. As concerns hepatitis 
B,  Italy  is  the  only  country  which  has  introduced  compulsory  vaccination  for  the  entire 
population, since the incidence there is higher than in any other country. 
11 31.  This diversity  is  borne out by  WHO  statistics  (1991).  They  show that more than 90%  of 
children in the European Community are vaccinated against diphtheria and tetanus, except in 
Ireland (65%) and  Spain (86%).  Similarly more than 90% are vaccinated against whooping 
cough,  except in Greece  (84%)  and  in  Italy  and  Ireland (  40%  ).  Child vaccination against 
measles ranges from 86% to 96% in the Member States, with the exceptions of Ireland and 
Italy (50%) and France (77%).  Finally, the child vaccination level  for poliomyelitis ranges 
between 88% and 99% in the European Community, with the exception of Ireland (63%) and 
Greece (77%). However, caution must be used in interpreting these statistics as the levels of 
vaccination  cover are  calculated  differently  from  one  Member  State to another,  since  no 
common criteria are applied and the figures are often merely estimates rather than accurate 
calculations.  To some extent,  low percentage can be explained by the absence of incentive 
measures when immunization was not compulsory.  · 
32.  Pursuing an effective vaccination policy at national level over a sufficiently long period clearly 
pays off. For example, in the case of very high initial incidence rates of tetanus, it has been 
possible to reduce them considerably. Thus, the rate per 100 000 dropped from 2.21 to 0.4 in 
Portugal between  1974 and  1991  as the corresponding vaccination cover rose from  53% to 
over 94%; it went from  1.33  to 0.14 in  Spain between  1980 and 1990; from 0.35 to 0.16 in 
Greece between 1974 and  1990;  and from  0.53  to 0.06 in France between  1974  and  1990 
where vaccination coverage grew from 79% to 92%. Where incidence rates were very low to 
begin with, a sustained vaccination effort has made it possible either to keep the rate very low, 
as in Great Britain where it remained at 0.03  between  1974 and  1989 or in the Netherlands 
where it decreased from 0.05 to 0.01 between 1974 and 1990, or to reduce it to virtually zero 
as  in  Denmark and  Luxembourg.  The results  are  even  more spectacular for poliomyelitis, 
where maintenance of extensive vaccination cover during a sufficiently long period - at least 
two  decades  - has  led  to  extremely  low,  even  zero,  incidence  rates  in  the  European 
Community nowadays, which is more or less tantamount to eradication of the disease. 
33.  The characteristic epidemiological features of influenza include the occurrence of  frequent, but 
unpredictable epidemics and periodic worldwide pandemics.  Outbreaks of influenza A or B 
infection are reported nearly every winter and vary in severity. Influenza surveillance provides 
important information on the timing and potential of an influenza outbreak. This information 
is used to coordinate an  appropriate public health response,  including issuing guidelines on 
vaccination and antiviral treatment and  assessing the need for additional  medical  resources. 
Vaccination  plays  an  important  role  in  reducing  mortality  and  morbidity  from  influenza, 
particulary in groups at risk.  It is most effective when the influenza strain which is likely to 
cause an outbreak is identified beforehand. 
34.  Mortality  from  influenza  increases  dramatically  with  age  and  the  presence  of underlying 
medical conditions. For instance, the 1989-90 epidemic in England and Wales was the worst 
since  1976  and  was  thought  to  be  responsible  for  over  29 000  excess  deaths.  Increased 
numbers of deaths from  cerebrovascular or cardiac  disease  were also  recorded  during  the 
epidemic, and it is probable that influenza played a part in these excess deaths. 
12 4.  COMMUNICABLE DISEASES WHICH REQUIRE SPECIFIC MEASURES 
(a)  Hepatitis 
35.  Hepatitis is a  condition characterised by inflammation of the liver of a toxic or infectious 
origin, provoking a change in the hepatic cells and consequently a change in normal liver 
functions.  Viral hepatitis is an infectious disease common throughout the world which - on 
account of its frequency,  severity of certain forms (acute, chronic,  cancerous) and cost of 
treatment - constitutes a serious public health problem.  Several viruses (A, B, C, D, E  and 
others, as yet unidentified) may cause hepatitis, two of which call for special attention. 
36.  Hepatitis B is one of  the major human diseases against which safe and effective vaccines have 
been available since 1982 in the Community. A preliminary analysis of a survey, conducted 
by the WHO Regional  Office for Europe,  estimates that 900 000 to  1 000 000 people in 
Europe are infected by hepatitis B every year. Of  these, 24 000. will die from the effects of 
the chronic disease, cirrhosis and liver cancer, and 90 000 will beeome chronic hepatitis B 
carriers. About 85  OOO.cases of  acute hepatitis B are reported every yearto the WHO Regional 
Office for Europe. The carriers also represent a large reservoir of infection which serves to 
perpetuate the infection-through various modes of transmission. 
37.  Among the types of  viral hepatitis, hepatitis C -the virus causing it having been identified in 
1989 -warrants special attention since its public health consequences are dire. There is no 
vaccine against it - in contrast to A and B hepatitis - and one of its special features is that 
people infected by the C  virus are  unaware of it for most of the time,  with the disease 
developing quietly over one or two decades, without any obvious clinical signs in almost 95% 
of cases. 
38.  The specialists acknowledge that in the natural  cour~e - now being mapped  out - of this 
disease 10% of  those who have the C virus will suffer cirrhosis several years after the initial 
infection, and of  those, 10 to 20% will develop cancer of  the liver unless secondary prevention 
measures  aie  taken.  Recent  epidemiological  studies,  undertaken  after  improvements  in 
screening tests, have shown that some 16 million people are infected by the C virus in the 
Community. This gives an idea of the size of the problem the public health authorities are 
facing or will face,  all the more so given the fact that at present - although the transfusion 
risk, i.e. of infection from donated blood, has been substantially reduced- there seems to be 
no plausible explanation for 50% of infections. 
(b)  Tuberculosis 
39.  Tuberculosis has been a major affliction of man  since ancient times.  In Britain during the 
industrial revolution of  the eighteenth century, a tuberculosis epidemic claimed so many lives 
that it became known  as  "the  white  plague".  Subsequently  the  disease  declined  steadily, 
probably due to a combination of several factors. 
40.  The persistence of a high level of tuberculosis in Europe can be attributed to several factors 
such as poor living conditions in certain regions of the world, changing eating and migratory 
patterns  and  resistance  to  some  strains  of tuberculosis  bacteria  to  standard  treatments. 
Tuberculosis is a disease which can be prevented by vaccination, yet there is less than 100% 
coverage by current vaccination programmes. 
13 41.  A retrospective WHO survey in 1992 indicates that 50 000 new cases were registered in the 
Community in 1991, half as many as in 1974, and that the decline in tuberculosis has halted 
in most Member States of the Community. There was a steady decline in the number of  cases 
reported  in  Germany,  Belgium  and  France between  1974  and  1991.  The  situation  had 
stabilised in Portugal and the United Kingdom, while increase~ had been observed recently 
in Denmark, Spain, Ireland, Italy and the Netherlands. There has been a 5% annual increase 
in France and the United Kingdom since 1992. These figures must be interpreted with caution, 
since the revival of interest in this communicable disease could have led to more diligent 
reporting of cases. Also, the definitions used are not always the same. 
42.  In some countries  of northern Europe,  immigration from  countries where tuberculosis is 
endemic  seems  to be  a  key  factor.  For example,  in  Germany  the  number  of cases  of 
tuberculosis reported in nationals continued to decline between.1986 and 1989,  while the 
number of cases reported among people coming from countries where tuberculosis is endemic 
rose by an average of  7% each year during this period. Similarly, in the Netherlands there was 
a 5% arinual decrease in the number of cases reported among Dutch nationals between 1984 
and 1990, accompanied by an annual increase of 13% among .the foreign population. The rise 
in cases  among the immigrant population  does not,  however,  seem  to have  crea~d new 
outbreaks of tuberculosis infection elsewhere. 
43.  As regards possible links between the AIDS epidemic (and,' more widely, IDV infection) on 
the one hand, and the resurgence of tuberculosis on the other, there is no clear evidence of 
absolute or systematic links. The proportion of AIDS patients with tuberculosis varies from 
2.3% in the United Kingdom.to 23.9% in Portugal. This proportion is also higher among drug 
addicts and among those infected via heterosexual transmission. 
(c)  Nosocomial infections  · 
44.  Among all the categories of communicable  disease  there is  one category which has  been 
known about for some time, but of which the general public is often unaware.  This is the 
category of  nosocomial infections, i.e. infections which patients contract in hospitals and other 
health-care establishments. 
45.  Their importance is now recognised and preventive measures, which are considered a priority 
in all health establishments, are underway. This is essential because the costs of nosocomial 
infections  are  considerable  both  in  human  terms  (morbidity  and  mortality  rates)  and  in 
economic terms (they cost.the Community tens of billions of ecus each year).  The rate of 
prevalence of nosocomial infections, i.e.  the ratio between the number of infections and the 
number of persons present in health care establishments varies but averages from 8 to 10% 
in the European Community as a whole. 
46.  The  occurrence  of these  infections  is  often  associated  with  invasive  procedures  during 
hospitalisation, such as surgery, catheter insertion or the use of  artificial pulmonary ventilation. 
But  it  is  also  facilitated  by  a  patient's  advanced  age  or  reduced  resistance  to  infection 
(immunodepression).  This  explains,  for  example,  the  recent  occurrence  of nosocomial 
tuberculoses among patients with mv infection. 
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47.  In  order of frequency,  nosocomial  infections  occur  most  frequently  in  the  urinary  area 
(roughly a half of  all cases), then in the pulmonary area and in operation wounds. The germs 
most often isolated are  Escherichia coli,  staphyl~occi and  Pseudomonas,  and  these  have 
developed a much greater multi-resistance to traditional antibiotics. 
m.  OVERVIEW OF ACTMTIES ALREADY UNDERTAKEN IN THE MEMBER 
STATES AND AT COMMUNITY LEVEL 
1.  THE COUNCIL 
48.  Councii  Directive 92/117/EEC  of 17 December  1992  concerning measures for  protection 
against specified zoonoses and specified zoonotic agents in animals and products of animal 
origin in order to  pr~vent outbreaks of food-borne infections and intoxications<
4> provides 
among other things for the collection· of data on the incidence of zoonoses and the presence 
of  zoonotic agents in the human .population, in domestic animals, in animal feeding stuffs and 
in  wildlife.  A  corresponding  Community  system  has  been  set  up  to  ensure  optimum 
implementation of actions to combat and prevent such diseases. 
49.  As regards other communicable diseases taking into consideration the existence of the single 
market and the free movement of persons and foodstuffs, the Council specifically addressed 
the need to take more account at Community level of  the risks of  the spread of  communicable 
diseases (including food-borne diseases) by adopting on 13 November 1992 a Resolution on 
the monitoring and surveillance of communicable diseasescs>  which invited the Commission 
to report  on  the  existing transnational  surveillance  networks  in this  field  and  to submit 
proposals  for  improving  and  extending  such  networks  where  this  would  prove  useful. 
Moreover, the Council in its conclusions of 13 December 1993<6), stressed the need for setting 
up an epidemiological network in the Community, which, whilst it should cover all diseases 
whether communicable or not, should as a priority collect data on communicable diseases with 
a view to acquiring better knowledge of their causes and their epidemiological context. This 
emphasis  on  epidemiological  surveillance,  analysis,  and  training  was  also  shared  by  the 
European Parliament which in its resolution on public health policy after Maastricht<7), called 
on the Commission to set up an epidemiological investigation service and to collect, analyse 
and disseminate. data on notifiable diseases and to encourage the setting-up and operation of 
exchange schemes for health· professionals. 
50.  On 3 May 1989 the Council adopted a Directive extending the scope of  Directives 65/65/EEC 
and 75/319/EEC<
8>,  which establishes a number of specific provisions governing the placing 
of vaccines on the Community market. 
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15 51.  Active  medicinal  products  against  mv are  categorised  as  "high  technology  medicinal 
products",  and  as  such  qualify  to  be  dealt  with  under  the  centralised  procedure,  which 
facilitates and speeds up the process of obtaining authorisations for such products to be placed 
on the market at Community leveL  Since  1987,  high technology or biotechnology-derived 
vaccines  have ·  been  covered  by  EC  pharmaceutical  legislation  by  virtue  of 
Directive 87/22/EEC.  Other vaccines  were brought  into  the  scope  of EC  pharmaceutical 
legislation by Directive 89/342/EEC.  A future anti-AIDS vaccine would be covered by the 
same  legislation  and  would  benefit,  through  the  centralised  procedure,  from  provisions 
controlling its placing on the market at Community level. 
52.  Council Directive 89/381/EEC covers stable industrially prepared blood derivatives intended 
for a large number of  patients, such as albumin, coagulation factors and immunoglobulins, but 
does not apply to whole blood, plasma and blood cells of human origin. These products are 
also subject to general provisions regarding manufacturing and marketing authorisation. The 
principles of good manufacturing practice laid down· in Directive 91/356/EEC, as well as the 
quality,  safety  and  efficacy  of the  tests  referred  to  in Directive  91/507/EEC,  are  thus 
applicable to these products. 
53.  In~_addition to these__general  provisionS,  which  are  applicable  to .all  medicinal  products, 
Directive 89/381/EEC contains several elements which relate more specifically to medicinal 
products derived from  human blood or plasma.  The m,easures for selection and control of 
blood donors recommended by the Council of  Europe and the World Health Organization have 
become compulsory as a result of this Directive. Moreover, for these particularly sensitive 
products,  the  Council  has  demanded  the  application  of  validated  manufacturing  and 
purification processes in order to guarantee, insofar as the state of technology permits, the 
absence of  specific viral contamination (notably by IDV). 
54.  In response to a request from the Council which had expressed concerns about the quality, 
safety and supply of blood and plasma products in the Community following the adoption of 
Council Directive 89/381/EEC on medicinal products derived from human blood or plasma 
in June 1989, the Commission submitted a Communication on "Blood Self-sufficiency in the 
European  Community".  This  Communication  identified  key  issues  of  concern  to 
Member States and specific actions for consideration. 
55.  On 13 December 1993, following approval of  the Commission's Communication on blood self-
sufficiency, the Council adopted Conclusions on self-sufficiency in the European Community 
which called inter alia for continued promotion of the quality and safety of blood collection 
and of blood-derivative production<
9>. 
56.  Council Directive 93/43/EEC of 14 June  1993  on the hygiene of foodstuffs<1°>  establishes a 
compl~e legal context for taking any appropriate measure to combat health risks inherent in 
foodstuffs. In dealing with every practical stage in the chain ·Of use of  foodstuffs, from storage 
conditions to transport to supply to the·consumer, this directive highlights the importance of 
food hygiene and,  in use,  should contribute significantly to ensuring that the requirement of 
a high level of health is met. 
(9) 
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16 57.  In its Resolution of 29 May 1986, the Council and the Ministers for Health of the Member 
States,  meeting within the Council, requested the Commission to organize an exchange of 
information and experience on AJDS<
11>.  As a result, on 11  February 1987 the Commission 
presented a Communication to the Council<
12>  laying down certain areas of action concerning 
AIDS prevention, information and education. 
58.  In the following years the Council and the Ministers for Health of  the Member States, meeting 
within the Council,  adopted a number of texts dealing with the health problems posed by 
AIDS,  the most· important of which  was the Decision  of 4  June  1991  establishing  the 
"Europe against AIDS" programme. 
59.  This health programme, scheduled to run from 1991 to 1993, focused principally on preventive 
actions such as information and education. As required by·the Decision, the Commission sent 
to the Council on 10 March 1993  a report on the implementation of  the plan of action in 
1991-1992. In this the. Commission reported on the means deployed to achieve the objectives 
laid down in  th~ Council Decision and commented on the early results obtained as well as on 
the relative weight and pertinenCe of the activities undertaken or requiring to be undertaken 
to give full effect to the aims of  the Decision, set against the backcloth  ~of thee spread of the 
epidemic. The Commission also stated its view that there would be value in further actions 
on the public health aspects of  IDV and AIDS being undertaken by the Community after the 
plan of action expired at the end of 1993. 
60.  Following consideration of  the Commission's report, the Council and the Ministers for Health, 
at their meeting of 27 May  1993, agreed to invite the Commission to take the initiatives 
necessary for continuation of  the actions of the "Europe against AIDS" programme in 1994, 
in anticipation of  the entry into force of  the Treaty on European Union, which provides in its 
Article 129 for Community action in the field of public health. 
61.  The  subsequent  evaluation  in the  Council  of the  effectiveness  of the ·work undertaken 
concluded that the broad structure of the areas of action contained in the Council Decision 
could be maintained,  but with a  number of modifications in the objectives pursued, the 
introduction of new areas, and the deletion of  others in order to reflect the changing needs of 
the Member States, increased knowledge of  the problems posed by the disease, as well as its 
evolution and trends. 
62.  In order to avoid any break in the actions under the "Europ.e against AIDS" programme, and 
in order to respond to the wishes of the Council, the Commission submitted to the Council 
on 29 September 1993 a Proposal for a Decision concerning the extension to the end of 1994 
of  the  1991-1993  plan  of  action  in  the  framework  of the  "Europe  against  AIDS" 
programme<
13>. 
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17 63.  Subsequent to the entry into force on 1 November 1993 of  the Treaty on European Union, the 
Council adopted on 13  December 1993  a Resolution concerning .the extension to the end of 
1994  of the  1991-1993  plan  of action  in  the  framework  of the  "Eprope  against  AIDS". 
programme<
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2.  THE EUROPEAN PARLIAMENT 
64.  As  long  ago  as  1984  the  European  Parliament,  in  adopting  a  number  of Resolutions 
concerning the fight against AIDS, revealed its growing concern at the inexorable spread of 
the epidemic and stressed the need for Community intervention. 
65.  The European Parliament has long taken interest in the frequency and inCidence of various 
communicable infectious diseases,  as reflected by the numerous written and oral  questions 
addressed to the Commission by MEPs. Two areas in particular have received attention and 
have  been  the  subject  of reports  by the  European  Parliament  Office  for  Scientific  and 
Technological Options Assessment (STOA). 
66.  The first of these reports,  published  in  1992,  concerns the protection of public health by 
vaccination.  The  conclusions -emphasise  the  need  for  more  information  on  the levels  of 
vaccination cover in all Member States, advocate the establishment of  a European programme 
for the surveillance of diseases preventable by vaccination and call for an aid policy to help 
European vaccine manufacturers in the face of  international competition. Comprehensive, and 
sensitive to all  aspects of the problem,  this  balanced  and reasonable report  constitutes an 
importat1t contribution to the public health debate, and one from which the Community could 
usefully draw inspirati<?n. 
67.  The second report, at present in the course of  being published, addressed the problems related 
to the r~surgence of  tuberculosis in Europe, and particularly its links with the AIDS epidemic 
and the movements of  populations emigrating from places where tuberculosis is endemic and 
living in precarious socio-economic circumstances. The STOA's conclusions focus on the need 
to  facilitate.  the  collection,  analysis  and  regular  dissemination  of epidemiological  data 
concerning tuberculosis cases and setting up a network of laboratories for monitoring strains 
of bacillus tuberculosis which are multi-resistant to antibiotics. 
68.  The European Parliament adopted two Resolutions during the July- December 1993  session 
dealing with self-sufficiency and the safety of blood and its derivatives.  The first requested 
the  Commission  and  Council  to  approve  an  action  plan  designed  to  improve  safety  and 
promote  self-sufficiency  through  voluntary  unpaid  donations.  The  second  called  for  the 
strengthening  of controls  to  ensure  the  safety .of blood  and  blood  products  and  for  the 
drawing-up of an  instrument which would guarantee the monitoring of the safety of blood 
from donation to use,  and the setting up  of a European blood safety authority. 
(14)  OJ No C 15,  18.1.1994, p.  4. 
18 IV.  COMMUNITY APPROACH 
1.  Objectives and means 
69.  As indicated in the Commission's Communication o~  the frartiework for action in the field of 
public health, Community action will, in particular, focus on encouraging cooperation between 
Member States,  lending support to their action  and  promoting,  in close  c~ntact with the 
Member States, coordination of their policies and programmes. In practice, this will involve 
the development and implementation of networ~s, joint actions and information exchange 
systems. 
70.  Future Community action  in the public health field  must take account, 'inter alia,  of the 
principle of subsidiarity and the considerations set out in paragraph 27 of the Commission's 
Communication. Actiyities should be selected on the basis of  prior appraisal and should yield 
a Community added value while achieving maximum cost~ciency. 
71.  As  stated  in  the  introduction,  'the  criteria  listed  in  paragraph  54 of the  Commission's 
Communication  are  satisfied  from  a  public  health  perspectiye  since  AIDS  and- other-
communicable diseases undoubtedly can cause significant premature death, have a significant 
morbidity and potential to devastate unprotected populations, constitute a significant risk for 
each individual and for the society as a whole, have major socio-economic impacts, especially 
as regards intervention and treatment costs, and moreover practicable measures of  prevention 
exist. The lessons of the first AIDS plan, as established in the evaluation process, show that 
there is substantial scope for added value from Community actions, both from economies of 
scale and from dissemination of  the results of projects. 
72.  The  Commission  proposes,  in  paragraph  50  of its  public  health  Communication,  four 
objectives which should form the basis of Community action: 
(i)  to pre~ent premature death which particularly affects the young and working population; 
(ii)  to increase life expectancy without disability or sickness; 
(iii)  to promote the quality of life by improving general health status and the avoidance of 
chronic and disabling conditions; 
(iv)  to promote the general  well-being of the population particularly by minimizing the 
economic and social consequences of ill health.  ·· 
This programme has to address all of these objectives. 
73.  The following criteria in particular will be used in future in selecting projects for CommunitY 
support in this field: 
activities on a scale which Member States themselves could not,  or could only with 
difficulty, implement; 
activities,  the joint implementation of which would offer obvious benefits even after 
taking account of the extra costs involved; 
activity· which,  because of the complementary nature of work being done at national 
level, enables significant results to be obtained in the Community as a whole; 
activity which leads, where the need is recognised, to the establishment of  best practice 
norms and standards; 
19 activities which contribute to the strengthening of solidarity and social cohesion in the 
Community, and promote its overall harmonious  developm~nt. 
2.  The Public Health Framework and  the Community action programme on AIDS  and 
other communicable diseases 
74.  In drawing up the proposed Community programme the Commission has t.aken  fully  into 
account the substantial programmes that Member States already have. In accordance with the 
principles developed in the Commis~ion's  Communication on the public health framework, the 
proposed Community programme is intended to complement and enhance the effectiveness of 
Member States' actions and to avoid any duplication of work. 
75.  The Commission seeks to ensure with its proposals that actions on the prevention of  AIDS and 
other communicable diseases enjoy maximum priority and adequate funding and are given 
precise objectives. Pnority will be given to large-scale wide-impact projects involving as far 
as possible the participation of governmental  and  non-governmental  organizations with  a 
proven record in this field.  · 
76.  The Community  ~{)ach must  be  designed  to ensure  the  coherence  and  continuity  of 
preventive actions. The programme of activities has to address _!Nery stage of the prevention 
process,·  including  information  and  data,  education,  specific  preventive  interventions; 
counselling  and  support.  It must  also  include  all  parties  and  settings  involved  in  these 
activities, in order to promote the development of the necessary skills, enhance cooperation 
between those undertaking actions, and foster coordination between those initiating preventive 
actions and the competent authorities. To achieve the maximum effect, the Commission will 
give particular support to the creation of  networks of  organizations in the different fields and 
to strengthening cooperation between existing networks. 
77.  As regards health education, health promotion, training, information, and actions in relation 
to communicable diseases, these are to be conducted partly under the programme on health 
promotion, Cducation and training and partly under the proposed programme focusing on two 
particular areas, namely: 
sexually  transmitted  diseases  (STDs),  with  special  emphasis  on  health  education 
initiatives  for  young  persons.  These  could  take  the  form,  for  example,  of 
education/information campaigns, using appropriate communication techniques, either 
for the general public or for particular groups in particular environments; 
diseases which can be prevented by vaccination. Information on vaccination campaigns 
for  certain  diseases  such  as  tuberculosis  or  the  triple  combination 
measles/mumps/rubella,  aimed  at  parents  or  health  professionals,  especially  family 
doctors,  is  deemed  to  be an  area in  which  the  Community  can  make a  substantial 
contribution. 
20 3.  Other instruments of  Community action 
78.  Special attention will be paid to the obligation contained in Article  129 which states that 
health protection requirements shall form a constituent part of  the Community's other policies. 
Many aspects of  Community policy impinge on the prevention of  communicable diseases and 
the Commission undertakes in its Communication on public health to ensure that full account 
is .taken of health protection and communicable disease prevention issues. The Commission 
has established appropriate procedures to ensure that this commitment is respected through 
adequate coordination and consultation in the development of relevant policies. In addition, 
the Commission will submit on a yearly basis a report on the health protection aspects of 
policies which will form part of  the Commission's Annual Report. 
79.  The following are examples of other Community policies and instruments likely to have an 
impact on the prevention of commuriicable diseases: 
certain instruments con"Celllingthe completion of  the single market and consumer policy, 
particularly as regards drug precursors, pharmaceutical products in particular.vacc;ines, 
medicinal products; 
social  affairs  policies  and  instruments,  particularly  concerning  migrants,  poverty, 
employment, .protection of workers' health and safety and the European Social Fund; 
education and training for young people and health professionals, and activities targeted 
at young people in the field of culture, communication and information; 
instruments designed to protect citizens' rights and ensure free movement of  information 
·such as personal data protection measures. 
80.  The specific programme of  research and technological development in the field of  biomedicine 
and health (1994-1998)  lays stress  on the integration of basic and  clinical  research  and 
includes the following: 
viro-immunological research, genetics, and the molecular and structural .... iology of  HIV 
and its variability; 
research towards the development of a safe and effective vaccine against AIDS, and of 
markers to evaluate its effectiveness and to monitor the evolution of the disease; 
the  identification,  synthesis  and  evaluation  of anti-viral  components  and  of drugs 
designed to combat AIDS; 
clinical research centred on clinical trials, the treatment of AIDS and its opportunistic 
diseases, including research on the prognosis and progression of these diseases and the 
impact of treatment; 
studies of host response, pathogenesis, experimental models and new pathologies, and 
of resistance to conventional  forms  of therapy,  taking into  account the  problem  of 
hospital infections. 
81.  Significant progress has been achieved in the fight against AIDS thanks to AIDS research 
· supported and coordinated by the Community. 
21 82.  The establishment of  the biomedicine and health research programme (BIOMED 1) under the 
third Framework Programme has enabled more than 6 000 research teams to collaborate with 
each  other within  400  networks  set up  to encourage  cooperation between research teams 
throughout the European Union and the European Economic Area and between complementary 
disciplines, with a view to tackling health problems which would be difficult to resolve in a 
more limited context. 
83.  As regards medical  and biomedical research specifically into communicable diseases other 
than  AIDS,  the  Commission  has  focused  on  a  certain  number  among  them  under  its 
BIOMED 1 programme and intends to do the same in the following phase, BIOMED 2. Even 
though the research did not relate  particularly to public health,  some special  efforts were 
undertaken by the European teams, for example in the field of  tertiary prevention in the case 
of hepatitis C, this being a communicable infectious disease which often develops into liver 
cancer or exposes those infected to the risk of  Lyme borreliosis. Also worth mentioning is the 
study concerning specific genetic markers in connection with the molecular epidemiology of 
tuberculosis,  a new discipline which needs to be developed much further but is clearly of 
significance for public health and-the serious problem of  the tuberculosis bacterium's multiple 
resistance to antibiotics. 
4.  · Cooperation between Member States 
84.  On the basis of  previous work, potential priority fields for cooperation between Member States 
have already been identified. These include: 
exchanges of information  on management regimes  for  people with IllV and  AIDS, 
including external maintenance and care in the community; 
cooperation on improving the methodology for evaluating care and therapeutic regimes, 
e.g. drug utilisation'; 
consideration of access to treatment and care and how to meet the needs of particular 
groups, such as children, pregnant women and migrants. 
85.  Where appropriate,  the  Community will  encourage cooperation between Member States in 
these fields by supporting exchanges of  information and experience and dissemination of best 
practice.  Cooperation will  also  be  encouraged  through  the  development  of networks  and 
support for programmes or pilot projects addressing objectives shared by the Member States. 
5.  Cooperation with International Organizations and Third Countries 
86.  The activities of  the Community programme should both add to the effectiveness of  the global 
fight against AIDS and profit from relevant experiences gained in non-Community states and 
the work of international  organizations.  The activities of the Council of Europe such as on 
ethical questions and the World Health Organization's (WHO) work in many areas of public 
health has to be taken into account in the implementation of the programme. Equally, actions 
should  go  hand-in-hand  with  those  taken  by  non-Community  states  and  international 
organizations·. Cooperation in this field is therefore necessary, leading, where appropriate, to 
joint action. 
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87.  The Commission intends to: 
build  upon  existing  cooperation  with  the  WHO,  the Council  qf Europe  and  other 
international  bodies by,  for  example,  developing joint actions  and  employing their 
expertise in specific tasks; 
strengthen cooperation with third countries where possible, by promoting joint actions, 
involving them in Community projects and providing assistance for th~r programmes; 
contribute  to the  WHO's  objective  of eradicating  the following  diseases:  measles, 
mumps, congenital rubella, neonatal tetanus, diphtheria and poliomyelitis. To this end, 
the Commission intends to establish an effective partnership with the WHO Expanded 
Programme on Immunization (EPI), which includes those responsible for implementation 
of the EPI in each Member State; 
set  up  consultation  and  cooperation  with  the  WHO for  the joint prOduction  of an 
information  instrument  based  on  the  diverse  surveillance  data  collected,  for 
dissemination to specialists. 
88.  The PHARE programme, set up in 1990, provides financial and technical support for reform 
in the countries of Central and Eastern Europe.  In this context it provides support for the 
restructuring of health systems intended to improve their quality and effectiveness. Activities 
against AIDS can be supported where they are included in priority action areas such as the 
development of training,  health promotion and prevention measures.  Similarly, assistance 
may be available under the TACIS programme for the newly independent states of  the former 
Soviet Union. 
89..  The European Community has initiated AIDS  activities for developing countries under its 
development  programme,  on  the  basis  of r~solutions by Parliament and  the  Council  of 
Ministers~
15>.  Drawing  on  the  lessons  of 7  years  experience  of support  programmes  in 
developing  countries  the  Commission  has  presented  to  the  Council  a  Communication 
(COM(93) 479) defining main policy principles and priority strategies for the Community and 
the Member States in the fieldof.IDV/AIDS in developing•countries.  The Communication 
was  endorse<I  by  a  resolution  of the .Council  in  May  1994.  The  Commission  has  also 
submitted a more general communication entitled "The Community and Member States' policy 
on cooperation with the developing countries in the field of health" (COM(94) 77). 
90.  Under the Lome Conventions, very significative efforts have been, and are being, implemented 
to  support  ACP  countries  in  developing  health  care  systems  which  could  contribute  to 
_ efficiently  reduce  the burden of communicable  diseases.  Special  attention  is given to the 
development of preventive activities at peripheral level, the improvement of  the physical and 
financial  accessibility to basic health care and  essential  drugs,  particularly antibiotics.  The 
EC/ACP AIDS programme was launched in 1987, with the collaboration of  the ACP countries 
(the Mrican, Caribbean and Pacific countries linked by the Lome Convention). A year later, 
in  1988, the Community's AIDS programme was extended to cover all developing countries, 
and  the  accent was placed  specifically  on  prevention.  The  Commission's  total  financial 
contribution for the period 1987-1992 was ECU 74.8 million, excluding funds allocated for 
(15)  Parliament Resolution  on  AIDS,  OJ  No C  88,  14.4.1986,  and· Council  Resolution, 
OJ No C 184,  23:7.1986~ 
23 research. The Member States contributed ECU 156.4 million over the same period, bringing 
the Twelve's total contribution to ECU 231.2 million. 
91.  Since 1988 the European. Community's research programme in the field of life sciences and 
technologies for developing countries (EC-STD) has also focused on specific aspects of the 
AIDS epidemic in developing countries. This programme contributes towards improving the 
balance between biomedical research and research on programmes, promoting socio-economic 
research,  developing the research  capacities of national  and regional  research institutes in 
developing countries,  and making more use of research results in order to ensure that the 
findings are rapidly put into practice.  · 
V.  COMMUNITY ACTION PLAN 
92.  In many respects the Community's involvement in public health activities for the prevention 
of communicable infectious diseases· other than AIDS is relatively new.  The Community's 
contribution  complements  ongoing work in this field  by  the Member States and  various 
international  organizations  competent in the  sphere  of public health,  notably WHO.  The 
priority actions described here are based on the emerging needs in the Member States and for 
which there is value in undertaking activity at Community level. 
93.  The general objectives are: 
to contribute to improving the prevention of communicable diseases in the Community 
by developing appropriate tools for the timely sharing of information and for ensuring 
prior consultation on communicable diseases and counter-measures, taking account of 
the existing  situation~ 
to develop and improve existing practical measures aimed at preventing the emergence 
or resurgence of such diseases. 
94.  As regards t~e IDVI  AIDS epidemic, the following three broad aims are involved in particular: 
to contribute towards reducing the spread of IDV  I  AIDS in the Community; 
to  contribute  towards  minimizing  the  adverse  consequences  of the  epidemic  for 
individuals and for society; and 
to cooperate with the efforts to combat AIDS and IDV outside the Community. 
A.  Actions on HIV  I  AIDS and sexually transmitted diseases 
1.  Data collection 
95.  National  epidemiological  data  are  currently  transmitted  to  the  European  Centre  for  the 
Epidemiological Monitoring of AIDS in Paris which produces statistics for the Community. 
The data available for the Community as a whole are, however, confined to AIDS. Owing to 
differences in Member States' approaches to HIV testing for epidemiological purposes, data 
on  the  prevalence  and  incidence  of mv infection  in  the  Community  are  not  available. 
Moreover,  differences  in  Member  States'  collection  systems  and  in  the  application  of 
definitions can delay  transmission of the data to the Paris Centre and  cause difficulties in 
interpreting data from different sources. 
24 96.  In addition to epidemiological data, accurate information on people's knowledge, attitudes and 
behaviour in respect of IDV/AIDS is .also important for developing policies and assessing 
preventive action. Member States' information varies, and that which is available is not always 
directly comparable. 
97.  Finally,  the  measures  taken  to  combat  AIDS  and mv in the  Member  States  consume 
substantial  resources  of finance  and  personnel,  and  these  are  likely  tQ  increase.  The 
development and promotion of objective parameters to assess the effectiveness of prevention 
measures  is important,  as  is the  exchange of information  and experience which  enables 
Member States to compare actions, utilise the best practices developed so far and learn from 
each other about what has proved effective. 
98.  The objectives of Community actions could be: 
to improve the collection, analysis and dissemination of  epidemiological and other data 
on AIDS, and increase the amount of data available on· mv  infection while ensuring, 
insofar as identifiable pers<>nal data are concerned, that suitable safeguards are in place 
to protect the privacy of individuals; 
to  improve  the  available  information  on  AIDS-related  knowledge,  attitudes  and 
behaviour of the general public and target groups; 
to improve the quality of  information on preventive measures and their effectiveness and 
promote its diffusion. 
99.  The actions to be taken to achieve these objectives could be: 
to strengthen cooperation and exchanges between Member States in order to improve 
the quality, comparability and accessibility of  AIDS data and to explore how more data 
on mv could be obtained,  in this context the establishment of equivalent levels of 
protection for personal data at Member State level is clearly a priority; support for the 
European Centre for the Epidemiological Monitoring of AIDS to enable its work to be 
further developed; 
to collect, analyse and disseminate existing information on the knowledge, attitudes and 
behaviour of  the general public and specific target groups and about preventive measures 
undertaken in the European Community: development of  further Eurobarometer surveys 
of the general public's knowledge and attitudes concerning AIDS; 
to promote the development and use of  assessment parameters to assess the effectiveness 
of the preventive measures, including the number and subject-matter of helpline calls, 
.level and kind of media coverage, and trends in the incidence of sexually transmitted 
diseases. 
2.  Measures for children and young people. 
100.  Children and young people are best informed about the diseases at an appropriate time as part 
of the process of growing  sexual  awareness and personal development.  Information about 
IDV/AIDS and STDs provided to young people who may be tempted to experiment with high-
risk activities· relating to sex and drug abuse helps them to minimize the risks of  infection and 
to comprehend the impact of the diseases.  Such information can be provided both within a 
formal educational setting and elsewhere, whether in youth and sports clubs, during organized 
holiday activities or at entertainment venues. 
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• 101.  Wherever the infonnation is provided,  it must take account of age,  level  of maturity and 
cultural, religious and social background. Moreover, there are a number of specific settings, 
such as penal and military institutions, orphanages and residential homes for which tailor-made 
infonnation  would  be. useful,  and  also ·specific  groups  such  as  children. from  disrupted 
backgrounds, those with learning difficulties, and drop-outs and 'streetkids' for whom special 
initiatives need to be developed. 
102.  General  health  and  sex  education  programmes,  which  cover physical,  mental  and  social 
develQpment and personal relationships, and also training for teachers and others involved are 
dealt with in the proposed programme on health  promotio~, education and training. 
103.  The objectives to be pursued could be: 
to promote the provision ofinfonnation on HIV/AIDS and STDs to specific groups of 
children and young people in specific settings; 
to strengthen  cooperation  and. exchanges  between the national  authorities and  other 
organizations engaged in Sl1ch work in order to improve the consistency of  infonnation 
provided in the different Member States. 
104.  The actions to be taken to achieve these obiectives could be: 
promotion of initiatives to provide infonnation relevant to specific groups of children 
and young people on  their knowledge,  perceptions,  behaviour and needs in specific 
settings in relation toHIV/AIDS and SIDs and to exchange educational and training 
materials and promotion of pilot projects; 
encouragement of  studies and exchanges analysing current provision ofHIV/AIDS and 
SID infonnation to children and young people especially outside the educational setting, 
including issues arising in specific settings and for specific groups, and promotion of 
pilot projects. 
3.  Prevention of  HIV and SID transmission 
105.  Infonnation aimed at reducing sexual  transmission  of mv and  STDs  among  the general 
population  must be complemented by  specific preventive initiatives targetted  at particular 
groups other than children an,: ;oung people who may be at higher risk or at settings where 
particular problems  arise.  Experience  indicates  that  such  measures  would  be of value  to 
prostitutes and their clients, injecting drug users, travellers and tourists, for penal institutions 
and for health service professionals. 
106.  The European Community has already taken steps to ensure that condoms are manufactured. 
to the highest standards.  But there are also other issues to address,  such  as  ensuring that 
people use condoms properly and thy need to develop and promote new methods of protection. 
107.  The objectives to be followed could be: 
to reduce mother-to-child transmission of IDV; 
to reduce mv  and STD transmission in specific settings, such as penal institutions and 
hospitals, where there are particular problems; 
26 to reduce HIV and  SID transmission among groups whose members may engage in 
high-risk behaviour, notably injecting drug users and sex workers; 
to ensure that condoms available in the Community are as safe as possible when used 
correctly and to promote other methods of protection for use by women. 
108.  The actions to be undertaken could include: 
information  on  transnational  tourism  and  travel between  the  Community  and  non-
Community states and  promotion of appropriate pilot projects eg.  in tourist resorts or 
frontier areas;  · 
information  for pregnant women,  in particular  drug users,  who  may. be at  risk  of 
transmitting mv infection to their children; 
information  for  people  with  IDV/  AIDS  and  SIDs in  penal  institutions,  including 
information for prisoners and  the existence of harm-reduction measures  such as  the 
provision of syringes for injecting drug users; 
evaluation of the mv  I  AIDS related knowledge~ attitudes and beha:viour of drug users 
and of mv prevention strategies for them; exchange of information on supplying safe 
injecting equipment and methadone programmes;  .  " 
exchanges of information on the situation of those at particular· risk of mv and SID 
infection, including sex workers and women involved with drugs,  and on the actions 
being undertaken;  · 
exch~ge of information  on  the  development  and  promotion  of new  methods  of 
protection. 
4.  Safety of  blood and blood  products 
109.  The  administration  of IllY-contaminated  blood  and  blood  products  to  luiemophilia  and 
thalassaemia sufferers and others requiring transfusions in recent years and .the ensuing tragic 
consequences have underlined the potential hazards of blood transfusion and highlighted the 
importance  of ensuring  the  safety  of blood  and  its  derivatives,  and  the  need  to achieve 
Community.  self-sufficiency  in  blood  as  source  mat~rial  for  products  covered  under 
Directive 89/381/EEC, based on voluntary non-remunerated donations. 
110.  The control of  blood and blood products to en.sure that they are safe for· use is a matter which 
is currently being examined by the Commission in close collaboration with the Member States, 
with a view to identifying what further common rules will be required.  The results of this 
examination will be made available in a Communication which· the Commission intends to 
transmit to  Council  and  the other Community institutions in due course.  In addition,  the 
Commission  is  pursuing  work  in  close  contact  with  the  Member  States,  concerning  the 
assessment of the situation in the Community as regards self-sufficiency, survey of attitudes, 
behaviour and practices as regards donation and its promotion, optimal use of  blood and blood 
products,  and assistance in  creating networks so as to ensure exchange of information and 
facilitate transfers of blood and blood products. 
27 5.  Social and  psychological support 
111.  The  social  and  psychological  needs  of the  rising  numbers of people directly  affected by 
IDV/AIDS are putting pressure on Member States' service provision. A particular problem is 
that of families where one or more patents and children are infected.  Such families face 
enormous difficulties, often including stigmatisation and discrimination. 
112.  In response to these problems one significant trend throughout the Community is for non-
governmental bodies to play an increasing role in providing information, care and social and 
psychological support. An accompanying trend has  been the growth of self-help groups for 
people with mv. Areas of  non-medical support can profitably be addressed at the Community 
level with a view to-assisting national efforts.  · 
113.  The objectives in this field could be: 
to assist Member States to improve the effectiveness of their provision for social and 
psychological support 
to support the activities of non-governmental bodies,  including self-help groups,  and 
strengthen their capabilities. 
114.  The actions to be carried out could include: 
exchanges of  experience about models of assistance and support, the promotion of  pilot 
projects and of studies on the psycho-social.aspects of the disease 
exchanges on the needs of families with members infected with IDV; 
elaboration of  manuals, bulletins. and directories providing information on transmission 
of mv, care and therapy, including organizations providing advice and support; 
encouragement ofnetworks of  organizations, particularly in the voluntary sector, in these 
areas. 
6.  Combatting discrimination 
115.  Discrimination against people with IDV and AIDS and those close to them by, for example, 
excluding them from obtaining certain kinds of employment, housing, insurance, education or 
health care is both morally objectionable and undermines public health measures. In the face 
of  prejudice and stigma mv  -infected individuals are more likely to conceal their seropositivity 
- or even be deterred from discovering their sero-status - and less likely to maintain contact 
with health and social services which could assist them. 
116.  Unless people voluntarily come forward for such contacts, and unless people's confidentiality 
and fundamental freedoms are protected, the disease will go undetected, making it harder to 
combat.  Moreover, when such discrimination is combined with prejudice against people in 
marginalised  groups  and  minorities,  such  as  homosexuals  and  immigrants,  severe  social 
tensions and disruptions can result. 
28 117.  Another form of discrimination is that of forcing certain groups to be screened for mv  for 
reasons unrelated to public health needs.  Practices such as the mandatory testing of certain 
groups  or individuals,  such  as  prisoners,  the  armed  services,  people  seeking  or holding 
particular jobs or people immigrating to or entering a  co~try, exist in various countries 
throughout the world.  Discrimination may also occur in the areas of HIV-testing without 
consent, the violation of  confidentiality about someone's infection and the corn.pulsory tracing 
of  sexual contacts. 
118.  In the light of this the objectives could be: 
to increase people's understanding of  AIDS and HIV and its effects a.tid reduce the fears 
and prejudices which can provoke discrimination;  · 
to assist Member States' efforts to combat discrimination, and to complement these by 
Community· act:lon, where appropriate. 
119.  The actions to be undertaken coUld be: 
'  revision with Member States of  the provisions on discrimination in the Resolution of  the 
Council and the Ministers for Health of  the Member States of22 December 198g<
1
6), and 
the measures taken in the Community to avoid or reduce discrimination; 
analysis of actual and potential discriminatory situations in the Community, such as in 
the fields of  employment, insurance, housing, education and health care and at frontiers 
and on compulsory screening for groups such as immigrants,  prisoners,  employment 
seekers, patients and the armed forces. 
B.  Specific Community measures for certain communicable diseases 
1.  Actions related to vaccination 
120.  One of the most effective methods of protecting_.an individual against certain communicable 
diseases is vaccination, provided an effective vaccine exists, which unfortunately is not always 
the case. Additionally, vaccination is one of  the most cost-effective health protection measures 
available for both populations and individuals. 
121.  In public health terms the risks of  an epidemic are lowest when a sufficient number of  persons 
have been vaccinated against a disease;  this  is also referred to as the level of vaccination 
cover,  the ideal,  of course,  being  100% cover.  Obviously,  the level of transmission of an 
infectious agent responsible for a disease within a given population depends on the level of 
vaccination cover within that population.  ·  · 
(16)  OJ No C 10,  16.1.1990, p.  3. 
29 122.  Consequently, an effective public health policy in this field involves defining, perfecting and 
implementing as effective a vaccination programme ·as possible,  and it is for  the Member 
States to cany out  such  a  programme.  Any national  immunisation  programme  against  a 
particular disease will necessarily comprise two stages. The first is to build up stocks of the 
appropriate vaccine, provide personnel to perform the vaccinations, and encourage people to 
be vaccinated.  The second is to verify the effectiveness of the programm_e:  this involves 
determining  the  level ·of vaccination  cover  and  changes  in this  level  over  time  and  by 
geographical area, monitoring the disease, and developing reference laboratory services for 
identifying the strains responsible for the disease. 
123.  Coherent  and  reliable  data  on  levels  of vaccination  cover  for  particular  diseases  or  on 
surveillance of such "diseases do not _generally exist. Additionally, the sources of information 
differ widely from Member State to Member State,  and the reliability of the information 
concerning immunisation schemes and the application of such schemes is uncertain.  These 
schemes are reflected in the vaccination schedules, which differ in terms of dose, age of  first 
injection, successive recalls, etc. The upshot is that there is no clear indication of  the level of 
protection of populations, and this poses a  pot~tial risk when imported cases of a disease 
appear in the population.  · 
124.  To  meet  the  requirement  of a  high  level  of health  protection,  a  vaccination  policy  at 
Community level could have the following public health objectives: 
to ascertain  as  accurately  as  possible the levels of vaccination cover for  particular 
diseases  in each  Member  State,  so  as  to provide  a  picture of the  overall  state  of 
immunisation in the European Community; 
to contribute  towards  improving  vaccination  cover wherever  necessary,  disease  by 
disease, by assisting in the launching of catch-up vaccination campaigns with a view to 
achieving a sufficiently high level of  vaccination cover to prevent the circulation of the 
inf~ous  agents responsible for the disease. 
125.  In this regard, the following actions could be envisaged: 
publication of  a document showing all the vaccination schedules at present available and 
in force in the Member States; 
definition  and  development  of  a  standard  methodology  for  assessing  levels  of 
vaccination cover; 
assessment of levels of vaccination cover in certain groups of the population such as 
·children.  · 
2.  Creation and development of  networks 
(a)  Surveillance 
126.  Involving as it does the collection, recording and analysis of data on communicable diseases, 
and then communication of the findings to the public health authorities, surveillance takes a 
number of forms,  depending on the type of communicable disease under investigation. 
30 127. ·  It can be carried out on the basis of  clinical and/or biological criteria (the data being furnished 
by general practitioners and test laboratories) or on the basis of surveys (either exhaustive or 
via sampling, depending on the type of disease under investigation: rare and serious diseases 
require  exhaustive  surveys,  e.g.  obligatory  notifications  or  morbidity  registers,  whereas 
common  and  less  serious  diseases  require  sample  surveys  of networks  of doctors  or 
laboratories). Additionally, the validity of the surveillance depends on the frequency of data 
collection, which may be continuous or periodic (but repeated at sufficiently dose intervals). 
Data may be collected passively (i.e. by awaiting the arrival of the information) or actively 
(i.e. through regular or permanent contact with the infoonation source). 
128.  Surveillance  also  depends  on  the.  administrative  level  involved  (i.e.  local,  national  or 
international), and the medium selected must. be the most appropriate foi the requirements 
(particularly  as  regards  speed),  e.g.  written  questionnaire,  telephone  or ·electronic  data 
transmission. Additionally, a truly rigorous surveillance operation should feature at least two 
independent and complementaly surveillance systems for the same disease: the exhaustiveness 
and representativeness of  the data collected can then be verified by comparing the data from 
the different systems. It requires· adequate resources in order to ensure a satisfactory level of 
operation and effectiveness. 
129.  All observations indicate that there is a need to improve, at Community level, the availability, 
quality, relevance and dissemination of data on certain communicable diseases. 
130.  The diseases subject to such surveillance can be grouped by category: 
diseases in which interest has been revived, tuberculosis (resistance to antibiotics) and 
blood transmission (hepatitis); 
diseases which can be prevented by vaccination, which justify a particular approach; 
nosocomial infections; 
gastrointestinal diseases (entero-haemorrhagic E.  Coli, salmonellosis, etc.) and certain 
other ~seases (legionellosis, etc.). 
131.  The objectives of such surveillance can be stated as follows: 
the early detection of epidemic outbreaks; 
the  establisrunent  of guidelines  for  epidemiological  intervention  to  contain  such 
outbreaks; 
identification of the medium and long-term trends with regard to individual diseases; 
identification of at-risk groups; 
study of changes in modes of transmission; 
evaluation of prevention strategies and corresponding measures; 
establishment of hypotheses for subsequent research and the formulation  of a public 
health plan. 
31 132.  In the light of these objectives at Europc:tan Community level, the following actions could be 
proposed: 
interlink Member States'  surveillance systems, with the emphasis on types of system: 
obligatory· notification of certain agreed diseases;  reporting on nosocomial  diseases; 
computer-linked networks of doctors  and laboratories;  one-off studies;  surveys on a 
given day;  . 
establish a  consensus for the adoption of a  case  definition  common to all  Member 
States,  as  well  as on data collection frequency  and the nature of the variables to be 
collected; 
improve the quality of  these systems by providing appropriate financial aid, to be jointly 
agreed with a group comprising servers and users of these systems; · 
offer assistance to Member  States requesting  it,  through  development of a  network 
structure based oil pooled resources. 
133.  In addition, as regards nosocomial diseases, the objectives of a Community policy could be: 
to improve awareness of  the existence of  nosocomial infections, which are often masked 
by  the  patient's  weakened  state  of health,  through  establishing  consultation  and 
coordination between the few existing national or regional surveillance networks in this 
field, with a view to achieving a  minimum level of comparability of results recorded at 
local level and identifying the role and distribution of risk factors; 
to promote  exchanges  of experience  on  the ways  in which  surveillance  results  are 
analyzed,  processed and  used  by the players in the field,  with a view to preventing 
nosocomial infections and reducing the related hospitalisation costs; 
to promote and support the gradual creation of  new surveillance networks so as to make 
the national public health authorities more aware of the problem and begin to include 
data  on  nosocomial  infections  in  their  routine  data  surveys  concerning  hospital 
conditions. 
134.  To achieve these objectives, the Commission could carry out the following specific actions: 
production  of standard  protocols  for  nosocomial  infection  surveillance,  to  include 
infection definition criteria, inclusion criteria and infection coding conventions; · 
creation of a reference database usable by all health care establishments in· the network, 
showing the incidence of certain important nosocomial infections by reference to types 
of  risk factor and types of  prevention practices used; by highlighting regional differences 
in prevention and treatment practices, the database will also make it possible to identify 
real problems which the aggregated national results tend not to reveal. 
(b)  Dissemination of epidemiological/information 
135.  The data collected in the surveillance of communicable infectious diseases must,  of course, 
after being validated and  interpreted,  be disseminated in a  suitably  processed form  to the 
public health authorities, so that they can define and adopt appropriate preventive measures, 
and to the players in the field, such as general practitioners, who are often the original sources 
of the information. 
32 136.  The information in question may serve one of two purposes: it may relate to an emergency 
situation  where  outbreaks  or epidemics  of a  communicable infectious  disease have been 
observed, in which case the public health authorities need to be alerted so that swift action can 
be taken, or it may relate to a routine situation, i.e. be no more than a periodic transmission 
of  the harmonised surveillance data produced by the national surveillance systems or networks. 
137.  In the first case,  succinct and  validated information must be  communicat~ rapidly using 
communication  systems  such  as  electronic  data  transmission.  In  the  second  case,  the 
information is more elaborate in nature and transmitted to the health professionals. and health 
authorities in the form of a specialist bulletin with a suitable, but not excessively long time-
lag. In both cases there is a requirement for the existence of a combination of a network of 
surveillance systems with validated information available on an appropriate communication 
m~~- . 
138.  In the light of the above, the Community's objectives in this area could be: 
improved knowledge and Wider dissemination (i.e. beyond the Member State of  origin) 
of existing national epidemiological bulletins containing both routine surveillance data 
(quantitative information) and specific original articles (qualitative information); 
creation of  an epidemiological information service open to health specialists and players 
in the public health field throughout the Community, the information being disseminated 
at intervals compatible with the requirements of public health action in the field. 
139.  In order to achieve these objectives the Commission could carry out the following actions: 
a  pilot study  to  establi~h the added value of a  weekly notice,  to be available to all 
existing national communicable disease surveillance. networks electronically; 
a pilot study for the production of a  two-monthly or three-monthly European Community 
bulletin of four to six pages,  designed for the same public as above and comprising 
proce~sed data. 
3.  Information,  education and training 
140.  Increasing the population's knowledge and understanding about communicable diseases and 
their implications is needed  to prevent transmission  and reinforce preventive efforts.  The 
development and implementation _of information campaigns,  whether aimed at the general 
public  or at  specific  groups,  are  a  key  instrument  in  prevention.  They  must,  however, 
essentially be undertaken by each Member State and what is appropriate and effective in each 
State varies according to their different traditions and to the different patterns of disease. 
Nonetheless, the Community can help Member States to draw on the results of experience 
elsewhere as coordinating campaigns across the Community can boost the overall  visibility 
and impact of national activities. 
141.  There is also an increasing need for information activities to respond to the growing mobility 
of the Community  population and for specific measures to be targetted at groups such as 
tourists, migrants, refugees and occupational travellers. Moreover, information is needed by 
those working in the media to ensure accurate reporting in relation to HIV/AIDS and certain 
other communicable  diseases.  Activities· at  the  Community  level  can  help  to  supplement 
national measures in this area. 
33 142.  Individuals with particular personal concerns need access to specific information and advice 
with proper respect for their privacy and confidentiality.  Together with specialised advice 
centres, telephone helplines and other response mechanisms using modern technology play a 
valuable role. However, such facilities do not exist everywhere in the Community, nor do they 
all provide the same high level of service. 
143.  Those  involved  in  communicable  disease  prevention,  care  and  support  activities  and 
professionals whose work may bring them into contact with infected people with, for example, 
HIV and AIDS or hepatitis, .such as the emergency services and prison staff,  need relevant 
information and training about the disease,  basic preventive  techniques~ but also how to 
provide advice and counselling. Initiatives to improve relevant training will help ensure that 
the resources available are used to the best effect in the whole CommunitY. 
144.  Because of a  shortage of manpower in the field  of epidemiology,  particularly as regards 
surveillance methodologies, and of  the wide diversity of  methods used to assess the extent of 
infectious diseases and control them, the use of  comparative evaluation methods is at present 
difficult. Any attempt to improve this situation has also to take account of the international 
dimension, and in particular the European Community dimension. This is particularly true with 
regard to grouping cases of a disease of unknown aetiology  . 
.  145.  Field.epidemiology involves the application of epidemiological methods to the surveillance, 
data production,  public  health  action  and  control  of communicable  diseases,  so  that  all 
measures are taken to stop the spread of an epidemic outbreak and eventually extinguish it. 
146.  At present the information emanating from Member States is not comparable because of the 
wide diversity  of their surveillance  systems.  Added to this is the fact that few  epidemic 
outbreaks are detected and properly investigated. It is rare, when a public health problem of 
this nature arises, for a case investigation to be carried out and appropriate recommendations 
to be drafted, often because there is a lack of epidemiological training which would enable 
those serving the surveillance systems to deal with this type of situation. 
147.  There is therefore a need to provide specific training which would involve not only a basic 
academic element but also practical experience of  approximately two years in several Member 
States. This is a model which has proved its worth in the USA and Canada but which cannot 
be found anywhere in Europe. The aim is to train a limited number of specialists who would 
then  be capable of investigating outbreaks of epidemics,  controlling them  and preventing 
communicable infectious diseases.  · 
148. ·  Against this background, the Community's aim could be to improve public health practices 
with regard to the routine surveillance of  infectious diseases and epidemic outbreaks whenever 
and wherever these occur in the Community. 
149.  The objectives in this area could be: 
to increase the level of knowledge and understanding of the general public and specific 
groups about certain communicable diseases and their impact; 
to maximise the effectiveness of Mef!lber States' campaigns by coordinating activities, 
where feasible, and by complementing them with Community initiatives; 
34 to  extend  the  existing telephone  and  other response  mechanisms  and  improve their 
effectiveness and cooperation; 
to improve the skills and knowledge of  those directly involved or whose work may bring 
them into contact with communicable diseases; 
to monitor, and help to improve existing training courses.and materials; 
to ensure appropriate awareness of communicable disease prevention and other issues; 
to foster a multi-sectoral and multi-disciplinary approach to prevention. 
150.  With a view to achieving these objectives the Commission could: 
encourage exchanges between Member States and improve cooperation on information 
campaigns aimed at the general public and specific groups, including the development 
of ways to reinforce and link information campaigns by using CommUnity media and 
producing specific materials to give campaigns a Community dimension; 
promote the provision of  information for use in the workplace and in the framework of 
health screening and surveillance; 
investigate the provision of telephone and other response mechanisms,  and of centres 
providing  information,  and  encourage the formation  of networks  and  exchanges of 
personnel and expertise, and develop pilot projects; 
facilitate an examination of  the training programmes currently in use for health and other 
professionals coming into contact with communicable diseases in order to identify gaps 
and help to devise further-training programmes; 
promote new training  opportunities for those  directly  involved  with  communicable 
diseases and the exchange, of materials, experience· and personnel, and of trainers and 
students; development of pilot programmes involving exchanges between specific kinds 
of statutory bodies and voluntary organizations and implementation of pilot further-
training programmes for people whose work brings them into contact with HIV/  AIDS, 
such as personnel in the emergency services'l:I.Ild penal institutions; 
facilitate an assessment of  stafftrairung in non-governmental organizations and promote 
interchanges for the dissemination of expertise and best practice; 
0  • 
create a steering group, comprising representatives from the Member States, to examine 
how to improve the training for field  epidemiologists specializing in communicable 
diseases; 
help develop a network of public health epidemiologists with a view to defining action 
objectives and common methods. 
4.  Early detection and systematic screening 
151.  Systematic and early screening for communicable diseases is an important element,  both to 
limit the spread of such diseases within the population and also to improve the prognosis for 
affecte<J individuals, by making it possible to start effective treatment as soon as  possible. 
152.  Some communicable diseases give a clear and rapid indication of  their presence, thus making 
superfluous any  approach involving systematic and early screening for them.  The situation 
is different for the communicable diseases which develop quietly in a more or less chronic 
manner  (hepatitis  C,  certain  parasitoses),  for  particular  forms  of communicable  disease 
(tuberculosis), or, finally, for those with specific consequences among certain at-risk categories 
of the population (toxoplasmosis in pregnant  women).  Due to the hidden  nature  of these 
communicable  diseases,  early  screening  for  them  must  include  supplementary  targeted 
35 examinations: specific serological analyses for hepatitis C and toxoplasmosis, lung X-rays for 
tuberculosis, parasitological examination of stools for certain helminthiases, etc. 
153.  Analysis of  the situation in the Member States shows that the methods of early and systematic 
screening  for  such communicable diseases  often  vary  and  that it would be beneficial  to 
promote exchanges of information and experience in this field. Such exchanges could lead to 
the start of pilot projects and the drawing-up of recommendations at Comm~nity level. The 
experience gathered from  early and systematic screening for an  initial number of specific 
communicable diseases could be applied to other diseases if  the associated feasibility studies 
and cost/benefit analyses showed this to be useful.  · 
154.  The objectives could be ~s follows: 
to contribute  t<;>  the development  and  establishment of early  detection  and  effective 
screening systems for communicable diseases; 
to  spread  the  use  of appropriate  practices  based on  guidelines  to be drawn  up  at 
European level in the quality assurance protocols for the screening and early diagnosis 
of communicable diseases; 
to improve the quality of communicable disease screening through the development of 
continuing training of health personnel. 
155.  The strategy could include the following key elements: 
the promotion of investigations on  the effectiveness and  feasibility  of screerung for 
certain types of communicable disease (tuberculosis, hepatitis, etc); 
support for the training of  health personnel, in particular in the context of  early detection 
and systematic screening of communicable diseases; 
cost-benefit  analysis  of screening  for  different  types  of communicable  disease,  in 
particular among pregnant women. 
VI.  CONSULTATION, ASSESSMENT AND REPORTS 
1.  CONSULTATION AND PARTICIPATION MECHANISMS 
(a)  Advisory Committee 
156.  The experience of the "Europe against AIDS" programme between 1991 and 1993 has showri 
the value of having an appropriate consultation and coordination structure. In order to permit 
the  fullest  possible  integration  of the  various  partners  involved  in  the  Programme,  the 
Commission will propose the creation of  an Advisory Committee composed of representatives 
from each Member State and chaired by the Commission. The composition of the Committee 
should ensure optimum representation of  the interests and expertise of  the national authorities, 
the  health  professionals  and  the  NGOs  competent  in  the  field  of  AIDS  and  other 
communicable diseases.  The Committee will  assist the Commission in all  policy questions 
relating  to  AIDS  and  other  communicable  diseases,  and  in  particular  relating  to  the 
programme's development and approach. 
36 (b)  Other participants 
157.  The Commission will encourage the Member States to set up national coordination committees 
for  the  programme  on  A.IDS  and  other  communicable  diseases  in  order to  enhance the 
motivation  and·  involvement  of the  national · players.  These  national  committees,  the 
composition and functions of which will  be determined locally,  have already proven their 
worth, in other programmes,  in improving the coherence of actions undertaken at national 
level and in helping the national partners involved to work together more closely. 
158.  In  the  past  few  years  of the  Community  AIDS  programme,  the  NGOs  involved  have 
contributed generously to the realisation of  Community actions, both in funds and in expertise. 
In view of  the instrumental role in prevention, care and research played by these organizations, 
the Commission will- maintain and strengthen its links with them, both through the Advisory 
Committee described above and through direct links with them. 
159.  The Commission will seek, in particular, to involve other partners, as justified by the extent 
of its action on AIDS and communicable diseases and bY' the implications for other fields of 
action in the area of  public health. In this. context, the Commission will ensure that its action 
on AIDS and other communicable diseases is consistent with "horizontal" actions and with 
actions under specific action programmesaddressing other diseases. 
2.  ASSESSMENT AND REPORTS 
160.  The assessment of the action plan will comprise three main elements: 
a mid...;term  report on the execution of the Programme to the Council,  the European 
'  '  ,< 
Parliament, the Economic and Social Committee and the Committee of the Regions; 
an independent peer review evaluation of the major actions and studies funded; 
a  global  report on the  efficiency  and  effectiveness of projects undertaken under the 
action_ plan to be submitted to the relevant Institutions by the Commission at the end of 
the execution of the Programme. 
161.  Mid-term and global reports on the execution of the action plan 
The purpose of the mid-term report is to ensure that the institutions, and through them all the 
parties concerned,  are kept fully informed of the progress of the actions undertaken in the 
context of  this action plan. It  will include an analysis of  projects supported under the different 
actions and. a detailed examination of activities in other sectors relevant to AIDS and other 
communicable diseases. The Commission will also submit a final global report at the end of 
the action plan. 
37 162.  Independent peer review evaluation of the major actions an~ studies funded 
Experience acquired in the acti9ns between 1991  and. 1993 l.Jllder the "Europe against AIDS" 
programme has highlighted the need for more effective evaluations of the Programme, both 
nationally and at European level. Such evaluations would facilitate the transferability of  results 
of pilot projects from one country to another and hence increase the European added value of 
the Programme. In order to introduce effective evaluations of  this type, the Commission may 
consult national authorities and other experts in  the field in order to establish appropriate 
criteria and protocols. 
3.·  GENERAL INFORMATION ACTMTIES 
163.  In addition to th~ information activities contained in the Programme, the Commission will 
ensure that the general public and all. parties concerned have access to the results of  the most 
important actions, studies and assessments undertaken. 
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94/0222 (COD) EXPLANATORY MEMORANDUM 
1.  In its Communication of  24 November 1993 on the framework for action in the field of  public 
health, the Commission defined a framework for future Community action in order to attain 
the  objectives  on  health  protection  laid  down  in  Articles  3(o)  and  129  of the  Treaty 
establishing  the  European  Community.  The  role  of the  Community  is  identified  as 
underpinning the efforts of the Member States  in ·the public health field,  assisting in the 
formulation and implementation of  objectives and strategies, and contributing to the provision 
of  health protection across the Community, setting as a target the best results already obtained 
in a given area an~here  in the Community. Community action is directed to the prevention 
of diseases  and  the  provision  of health  information  and  education.  Health  protection 
requin:ments must .also be part of other Community policies. 
2,  Future Community action in the public health field must take into account,  inter alia,  the 
principle of subsidiarity and the requirement of proportionality. It is worth noting in this 
context, that the diversity observed  within and between- the Member States in respect of 
geography, climate, lifestyles, culture, socio-economic conditions and the environment is such 
that,  generally  speaking,  no  detailed  requirements  can  be proposed  by  the  Community. 
Activi1ies  must be selected  .. on the basis of prior appraisal  and  should yield a Community 
added value while achieving maximum cost efficiency. 
3.  The present proposal  sets out the objectives and action areas for a programme on AIDS and 
certaint other communicable diseases which is intended to run during the period 1995- 1999. 
The Community's role will  primarily be to promote cooperation between Member States, 
supp01t their actions promote co-ordination between their policies and programmes in close 
collaboration  with  th~  Member  States  themselves,  complement  their  actions,  where 
appropriate, with measures at the Community level and ensure that Community policies  in 
other areas -such  as  education,  social  policy  and  the  implementation of the  single market 
supp01t the prevention of these diseases. 
4.  The  aims  of the  programme  are  to  reduce  as  far  as  possible  the  spread  of certain 
communicable diseases, including mv and AIDS, in the Community, to minimize the adverse 
consequences for individuals and for society and to cooperate with efforts to combat them 
outside the Community.  In the light of  these aims, the Community approach must be designed 
to ensure the coherence and continuity of preventive action and thus must address every stage 
of the:  prevention  process  including  information  and  data,  education,  specific  preventive 
intervc~ntions, such as screening and vaccination where feasible and appropriate, counselling 
and support, and cover all  parties and settings involved at the various stages.  · 
5.  A wide range of preventive measures will be needed to pursue these aims,  and some of  these 
will have to be implemented in close liaison with other existing Community programmes such 
as those on research and development assistance, or those currently being developed, such as 
those on  dn.Ig  dependency;  health promotion,  education and training;  and  health data and 
indicators, and monitoring and surveillance of diseases. 
40 6.  The previous action programmes on AIDS emphasised a number of fields of activity.  It is 
proposed to continue these actions whilst extending the programme to include certain other 
communicable  diseases.  The  fields  of activity  identified  in  the  communication  on  the 
framework for  action in the field  of public health are:  epidemiological  data;  provision of 
information to the public and specific target groups; health education; training; early detection 
and screening; research; and cooperation with international organizations and third countries. 
Other priority areas  identified are gathering and disseminating various kinds of information 
on the spread of the diseases and the measures taken in response, measures for children and 
young people,  specifically targeted preventive interventions,  blood transfusion transmitted 
diseases, social and psychological support, combating discrimination and  screening tests. 
7.  The Commission wil! transmit a mid-term and a final global report on the implementation of 
the programme to the Council, the European Parliament, the Economic and Social Committee 
and the Committee ofthe Regions. Moreover an independant peer review evaluation will be 
conducted of  the major aCtions and studies funded. These will enable the institutions to assess 
the  progress  and  impact of the. work,  and of the  actions  undertaken  and the methods  of 
implementation could then be modified, if required. 
41 Proposal for a 
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94/0222 (COD)  _ 
THE EUROPEAN PARLIAMENT AND 11IE COUNCIL OF THE EUROPEAN UNION, 
Having  regard  to  the  Treaty  establishing  the  European  Community,  and  in  particular 
Article 129 thereof, 
Having regard to the proposal from the Commission(!>, 
Having n~gard to the opinion of the Economic and Social Committee<2>, 
Having regard to the opinion of the Committee of the Regions{3>, 
Whereas the prevention of diseases, in particular the major health scourges, including drug 
dependence, is a priority for Community action, requiring a global and coordinated approach 
between 1\fember States; 
Whereas AIDS is at present an incurable disease which, given its-modes of  transmission, can 
only be effectively combated by preventive measUres; 
Whereas  the  plan  of action  adopted  by  Decision  91/317/EEC  of the  CounCil  and  the 
Ministers for Health of the Member States, meeting within the Council<
4>,  in the framework 
of the "Europe against AIDS" programme expired at the end of 1993; 
Whereas, in their conclusions of 27 May  1993<
5>,  the Council and the Ministers for Health, 
meeting  within  the  Council,  emphasised  the · need  to  continue  the  activities  of the 
"Europe against AIDS" programme; 
(1) 
(2) 
(3) 
(4) 
(5) 
OJ No 
OJ No 
OJ No 
OJ No L  175,A.7.1991, p.  26. 
Doc:.  6946/93 SAN 36. 
42 Whereas, in consequence, the Commission submitted to the Council on 29 September 1993 
a Proposal for a Decision concerning the extension to the end of 1994 of  the 1991-1993 plan 
of action adopted in the framework of the "Europe against AIDS"  programme<6),  to ensure 
continuation  of the  Community  actions  to  combat  AIDS  pending  the  adoption  of a 
multiannual  action  programme;  whereas the Council  adopted on 2  June  1994 a  common 
position concerning that proposal<7),  with a view to extending the ffEurope  against AIDS  .. 
programme to the period 1994-1995; 
Whereas, in its conclusions of 13 December 1993<
8>,  the Council agreed that it  was necessary  _ 
for the Community as a whole to acquire a better knowledge of  diseases on the.basis of  their 
causes and their epidemiological context; 
-
Whereas,  in the  same  conclusions,  the Council  emphasized that all  smooth n,mning of a 
network for gathering epidemiological data requires that theoretical training in epidemiology 
and practical prep~ation  in epidemiology in the field be developed for the teams participating 
in the network; 
Whereas in their resolution of  13 November 1992<
9>,  the Council and the Ministers for Health 
meeting within the Council  invited the Commission to consider the existing arrangements 
which provide for cooperation between Member States in the field of  monitoring and control 
of communicable diseases; 
Whereas  the  actions  undertaken  at  Community  level  in  the  field  of ·AIDS  need  to  be 
continued  and  extended  to  cover  certain  other  communicable  diseases,  and  also  to  be 
consolidated within the framework of the action in the field of public health set out by the 
Commission<IO). · 
' 
Whereas the actions must take into account,  as  the Council requested in its Resolution of 
27 May 1993<
11>,  other actions undertaken by the Community in the field of public health or 
having an impact on public health; 
Whereas in its Resolution of 2 June 1994 concerning the framework for Community action 
in the field of public health<
12>,  the Council agreed that priority should be given at present to 
AIDS and other communicable diseases; 
Whereas, in accordance with the principle of subsidiarity, actions on matters not within the 
exclusive competence of the Community,  such as  action on illV/AIDS and  communicable 
diseases, should be undertaken by the Community only when, by reason of  its scale or effects, 
its objectives can be better achieved at Community level; 
(6) 
(7) 
(8) 
(9) 
(10) 
(11) 
(12) 
COM(93) 453  final  of 29.9.1993. 
OJ No C 213, 3.8.1994, p.  220. 
OJ No C ·IS,  18.1.1994, p.  6. 
OJ No C 326,  11.12.1992, p.  1. 
COM(93) 559 final of 24.11.1993. 
OJ No C 174, 25.6.1993, p.  1. 
OJ No C 165,  17.6.1994, p.  1. 
43 Whereas cooperation with the competent international organizations and with non-member 
countries should be strengthened; 
Whereas a multiannual programme is required, defining the objectives pf  Community action, 
the priority actions for the prevenion of AIDS  and other communicable diseases,  and the 
appropriate evaluation mechanisms; 
Whereas  the  objectives  of this programme  must  be  to  contribute  towards  improving 
knowledge concerning the prevalence and.pattems of lflV/AIDS and other communicable 
diseases, improving recognition of  risk situations and improving early detection.and social and 
medical support, with a view to preventing the transmission of communicable diseases and 
thus reducing the assocjated mortality and morbidity; 
Whereas, from an operational point of view, past actions to establish European networks of 
non-govemmental  organizations  and  to  mobilize  resources  should  be  maintained  and 
developed.; 
Whereas possible duplication of effort should be avoided by the promotion of exchanges. of 
experience· and by the development of information material for the public, health educators· 
and those who train the health professions; 
Whereas this programme should be of  five-year duration in order to allow sufficient time for 
the various actions to be implemented and to achieve the objectives set, 
HAVE DECIDED AS FOLLOWS: 
Article 1 
A  Community  action  programme  on  AIDS  and  certain  other  communicable  diseases  is 
adopted for a five'-year period. 
Article 2 
The  Commission  shall  ensure  implementation  of the  actions  set  out  in  the  Annex  in 
accordance with Article 5 and in close cooperation and partnership with the Member States. 
The institutions and organizations active in the field of the prevention of AIDS and other 
communicable diseases shall take part in them as well. 
Article 3 
The budgetary authority shall determine the appropriations available for each financial year. 
Article 4 
The Commission shall  ensure that there is consistency  and complementarity between the 
Community actions to be implemented under this programme and those implemented under 
other relevant Community programmes ·and initiatives. 
44 Article 5 
For  the  implementation  of the  programme  the  Commission  shall  be  assisted  by  an 
Advisory Committee,  hereinafter  referred  to  as  "the  Committee",  comprising  two 
representatives from each Member State· and chaired by a Commission representative. 
The representative of the Comission shall submit to the Committee a draft of the measures 
to be taken. The Comnuttee shall deliver its opinion on the draft, within a time limit which 
the chairman may lay down according to the urgency of the.matter, if  necessary by taking a 
vote. 
The opinion shall be re9orded in the minutes; in addition, each Member State shall have the 
right to ask to have its position recorded in the minutes. 
The Commission shall take the utmost account of the opinion delivered by the Committee. 
It  shall inform the Committee on the manner in which its opinion has been taken into account. 
Article 6 
1.  The Community will encourage cooperation with third countries and with international 
public health organizations, in particular the World Health Organization. 
2.  The EFTA countries, in the framework of the EEA Agreement and the countries from 
Central  and  Eastern  Europe with whom  the  CommunitY  has  concluded  association 
agreements may be associated with the activities described in the Annex, according to 
the provisions of those agreements. 
Article 7 
.  1.  The  Commission  will  regularly  publish  information  on  the  actions  undertaken  and 
opportunities for Community support in the various fields of action. 
2.  The  Commission  will  submit  to  the  European  Parliament,  the  Council,  the 
Economic and Social Committee, and the Committee of  the Regions a mid-term.report 
on the actions undertaken, as well  as an overall report at the end of the programme. 
Done at Brussels, 
For the European Parliament 
The President 
45 
For the Council 
The President ANNEX 
CO~lUNITY  ACTION PROGRAMME CONCERNING THE PREVENTION 
OF AIDS AND OTHER COMMUNICABLE DISEASES 
L  AC110NS ON HIV/AIDS AND SEXUALLY TRANSMITTED DISEASES 
A.  Data collection 
1.  Exploration with Member States of  ways to increase and improve A.IpS and IDV data 
at the Community· level,  and provide support to strengthen the work of the national 
epidemiological surveillance systems and the European Centre for the Epidemiological 
Monitoring of AIDS. 
2.  Gather, analysis and  dissemination information concerning preventive measures and the 
knowledge, attitudes and behaviour of the general public and target groups; promotion 
of the development and use of measures for assessing effectiveness and new surveys 
where existing information is inadequate, including Eurobarometer surveys. 
B.  Measures for children and youn& people 
3.  Encouragement of initiatives to ascertain and disseminate information about children's 
and young people's knowledge, attitudes and behaviour in relation to IDV/AIDS and 
STDs;, to examine current practice in providing them with information both within and 
outside formal  settings  such as schools and training institutions and  to promote the 
'exchange of educational and training material, and the setting up of pilot projects and 
networks. 
C.  Prevention of HIV and STD transmission 
4.  Examination and exchanges of information on problems and situations related to groups 
at risk (drug users,  sex workers,  homosexuals and bisexuals), risk situations (mobile 
populations and border areas, penal institutions); and modes of  transmission; exchange 
of experience on harm-reduction measures and preventive actions;  and promotion of 
appropriate preventive measures and of pilot projects. 
5.  · Promotion of information, advice and counselling to pregnant women who may be at 
risk of  transmitting IDV to their babies; exchange of  views and experience on screening 
pregnant  women;  and  co-ordination  of  research  on  minimizing  mother-child 
transmission. 
46 D.  Social and psychological support and combatting discrimination 
6.  . Exchanges of experience and information concerning models of  assistance and support, 
including  the  particular  difficulties  facing  families  with  infected  members,  and 
concerning  policies and practices on screening and discriminatory situations, promotion 
of analysies  and  pilot projects  on the psycho-social  aspects  of the disease,  and the 
setting up of networks of organizations providing information and assistance. 
ll.  SPECIFIC  COMMUNITY  MEASURES  FOR CERTAIN  COMMUNICABLE 
DISEASES 
A.  Actions related to vaccination 
7.  Support for initiatives designed to produce information on levels of vaccination cover 
in  the Community,  especially  among  children,  at-risk groups and persons living  in 
certain  risk  situations,  against  communicable  diseases  preventable  by  vaccination;. 
promotion ofinitiatives designed to improve the vaccination cover of  the general public, 
and  especially  of  at-risk  groups  and  persons  living  in  certain  risk  situations; 
encouragement  of  measures  designed  to  match  vaccination  schedules  to  the 
epidemiological context. 
B.  Creation and development of networks 
1  a.  Surveillance 
8,  Contribute to improving the quality of  Member States' surveillance systems, taking into 
account the views of servers  and users,  and  assist in the development of networks, 
based on  agreed  methodologies and  conditions of transmission of information,  prior 
consultation and coordination of responses. 
9.  Promote knowledge and exchanges of experience on the ways in which surveillance 
result3 of nosocomial infections are analysed,  processed and used by the actors in the 
field,  and encourage actions to increase awareness of the problems and inclusion of 
comparable and reliable data on nosocomial  infections in routine surveys concerning 
hospital  conditions,  and  support the  creation  of new surveillance networks for  such 
infections. 
2°.  Dissemination of epidemiological information 
10.  Contribute,  in  particular by  the provision  of the logistical  support necessary,  to the 
production  and  dissemination  of a  regular  information  notice  and  of a  European 
Community bulletin on communicable diseases· surveillance, comprising both routine 
surveillance data and reports on specific investigations. 
47 C.  Information, education and training 
11.  Encouragement of  exchanges between Member States on infonnation campaigns at all 
levels, development of  ways of  linking and reinforcing campaigns, such as provision of 
specific materials;  and utilisation of  telephone and other response mechanisms,  and 
development and promotion of activities to complement national efforts, including the 
setting up of networks and the exchange of experience and expertise. 
12.  Examination of  current training programmes for health and other professionals, and for 
those~  whose  work  brings  them  into  contact  with  certain  communicable  diseases; 
identification of weaknesses  and gaps,  and  devising and  promotion of new further 
training opportunities and programmes. 
13.  Improvement  of public  health  practices  with  regard  to the  routine  surveillance  of 
infectious diseases and epidemic outbreaks whenever and wherever these occur in the 
Community;  development of. a Community network of public health epidemiologists 
with  a view to defining common methods and tools and enhancing the capacity for 
coordinated response. 
D.  Early detection and systematic screening 
14.  Promotion of  investigations on the effectiveness and feasibility of  screening for certain 
types of communicable diseases (tuberculosis, hepatitis, etc). 
15.  Support _for  the training  of health  personnel,  in particular in  the  context  of early 
detection and systematic screening of communicable diseases; cost-benefit analysis of 
screening for different types of communicable disease, in particular among pregnant 
women. 
48 FINANCIAL STATEMENT 
1  TrfLE OF OPERATION 
Proposal for a European Parliament and Co1:1ncil Decision adopting a programme of 
Community  action  on  the  prevention  of AIDS  and  certain  other  c~mmunicable 
diseases within the framework for action in the field of public health 
2  BUDGET HEADING INVOLVED 
B3 -4305 (former item B3-430  1  ): Combating AIDS and other communicable diseases  . 
. 3  L.J!:GAL  BASIS 
(a) Actual legal basis 
Article 3(0) and Article 129 of the Treaty on European Union. 
(b) References 
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Resolution of  the representatives of  the Governments of  the Member States, meeting 
within the Council of29 May 1986, on AIDS (OJ No C  184, 23.7.1986, p.  21). 
Communication from the Commission of 11 February 1987 on the fight against AIDS 
(COM(87) 63  final). 
Conclusions of the Council  and of the representatives of the Governments of the 
Memb.er  States,  meeting  within  the  Council  of 15 May  1987,  concerning  AIDS 
(OJ No C 178, 7.7.1987, p.  1). 
Conclusions of the Council and of the representatives of the Governments of the 
M€,mber  States,  meeting  within  the Council  of 31  May  1988,  concerning  AIDS 
(OJ No C 197, 27.7.1988, p.  8). 
Conclusions  of the  Council  and  the Ministers  for  Health of the  Member  States, 
meeting within the Council of 15  December 1988, concerning AIDS (OJ No C 28, 
3.2.1989, p.  n. 
j 
Conclusions :of the  Council  and  the  Ministers  for Health  of the  Member  States, 
me:eting within the Council of 15 December 1988, concerning AIDS and the place of 
work (OJ No C 28, 3.2.1989, p.  2). 
Resolution of  the European Parliament of 30 March 1989 on the fight against AIDS 
(OJ No C 158, 26.6.1989, p.  477). 
49 Conclusions  of the  Council  and the Ministers for  Health  of the Member States, 
meeting within the Council of 16 May 1989, regarding the prevention of AIDS in 
intravenous drug users (OJ No C 185, 22.7.1989, p.  3). 
Conclusions  of the· Council  and the Ministers for Health of the Member  States, 
meeting within the Council of 16 May 1989, on awareness measures for health care 
personnel (OJ No C 185, 22.7.1989, p.  6). 
Conclusions of the  Council  and the Ministers for Health of the Member States, 
meeting within the Council of 16  May  1989,  on the improvement of the general 
system  for  collecting epidemiological  data,  including the  application .of the new 
definition of AIDS cases (OJ No C 185, 22.7.1989, p.  7). 
Conclusions of the  Council  and the Ministers for  Health of the Member  States, 
meeting within the Council of 16 May  1989, regarding future activities on AIDS 
prevention and control at Community level (OJ No C  185, 22.7.1989,  p~ 8). 
Resolution of  the Council and the Ministers for Health of  the Member States, meeting 
within the Council of 22 December 1989, on the fight against AIDS (OJ No C  10, 
16.1.1990, p. 3).  . 
Conclusions of  the Council ~d  the Ministers for Health, meeting within the Council 
of 17 May 1990, concerning medical and psychosocial support for persons affected 
by the AIDS epidemic (Doc.  7264/90 SAN 45). 
Conclusions of the Council  and of the Ministers for Health,  meeting within  the 
Council of 3 December 1990, on AIDS (OJ No C 329, 31.12.1990, p.  21). 
Decision  91/317/EEC  of  the  Council  and  the  Ministers  for  Health  of  the 
Member States, meeting within the Council of  4 June 1991, adopting a plan of  action 
in  the  framework  of the  1991  to  1993  "Europe  against  AIDS"  programme 
(OJ No L  175, 4.7.1991, p.  26). 
Resolution of the Council and the Ministers for Health, meeting within th_e  Council 
of 13 November 1992, on the monitoring and surveillance of  communicable diseases 
(OJ No C 326, 11.12.1992, p.  1). 
Report  from  the  Commission  on  the  implementation ·of  the  plan  of  action 
(Europe Against AIDS) in 1991-1992 (COM(93) 42 final,  10.3.1993). 
Conclusions of  the Council and the Ministers for Health, meeting within the Council 
of 27 May  1993,  on the implementation and  continuation of the "Europe Against 
AIDS" programme (Doc. 6946/93 SAN 36).  · 
Proposal  for  a  Decision  of the  Council  and  the  Ministers  for  Health  of the 
Member States, meeting within the Council, concerning the extension to the.end of 
1994 of  the 1991-1993 plan of action in the framework of  the Europe Against AIDS 
programme (COM(93) 453 final, 29.9.1993). 
50 Commission communication on the framework for action in the field of public health 
(COM(93) 559 final). 
Council conchisions of 13  December 1993  on the setting up of an epidemiological 
network in the Community (OJ No C 15,  18.1.1994, p.  6). 
Council Resolution of 13 December 1993 concerning the extension to the end of 1994 
of the 1991  to 1993 plan of  action in the framework of  the "Europe Against AIDS" 
programm~ (OJ No C 15, 18.1.1994, p.  4). 
Council Resolution of 2 June 1994 on the framework for Community action in the 
fieid of public health (OJ No  ..... ). 
4  DESCRIPriON OF OPERATION  - . 
4.1  General objective 
Implementation of a programme of Community  operations to prevent AIDS  and 
other communicable diseases. Parliament, the Council and the Ministers for Health 
of the Member States meeting within the Council have,  since the beginning of the 
epidemic, adopted a number of texts dealing with the public health problems posed 
by AIDS (see list above),  the most important of which is the Decision of 4 June 
1991  establishing the "Europe Against AIDS" programme. 
The aim of this communication  is to establish the necessary  basis for  extending 
Community operations against AIDS and expand them to cover other communicable 
diseases  while  taking  into  account  the  entry  into  force  of  the  Treaty  on 
European Union,  particularly Article  129,  which makes provision for Community 
action  in the  field  of public  health  and,  in particular,  against  the  major health 
scour~es. 
The .aim  of this programme is to encourage cooperation between Member States, 
support  their  operations  and  promote  coordination  between  their  policies  and 
programmes  within  the  framework  of the  prevention  of HIV/AIDS  and  other 
communicable diseases. 
Intermediate  objectives:  these  include  reducing  mortality  and  morbidity  due  to 
communicable diseases and reducing the risk of  infection by the AIDS virus or other 
infectious agents. 
Methods for achieving this objective:  stimulating Member States to develop their 
own  resources  for  the  prevention  of AIDS  and  other  communicable  diseases, 
pn::vention strategies and intra-Community cooperation, particularly through support 
for exchanges, identification and dissemination of best practice and the creation of 
networks; development of  guidelines and financial assistance for programmes or pilot 
projects aimed at improving the effectiveness of  prevention both among professionals 
in the social and health fields and among the general public. 
51 4.2  Period covered and arrangements for renewal or extension 
5 years:  1995-1999. 
Report  on implementation to be transmitted to the Council  and 
European Parliament during the third year of the programme: any 
modifications necessary 
Report to the Council and European Parliament at the end of the 
programme: renewal or adaptation procedures. 
5  CLASSIFICATION OF EXPENDITURE OR REVENUE 
Non-compulsory expenditure 
Differentiated appropriations 
6  TYPE OF EXPENDITURE OR REVENUE 
Subsidies  for  co-financing  with  other  public  and/or  private  sector  bodies 
(not exceeding a certain percentage of the total cost of such projects). 
7  FINANCIAL IMPACT 
7.1  Method of calculating total cost of operation (definition of unit costs) 
The  method  of  calculation  is  the  result·  of  experience  acquired  in 
implementing operations to combat AIDS and other communicable diseases 
(items  B3/4301,  later  B3-4305)  over  recent years,  taking  into  account 
medium-term prospects  set out in the  Commission communication  on the 
framework for action in the field of  public health. A total amount rounded off 
to ECU 50 million during the period 1995-1999 appears to be necessary for 
these activities. The yearly allocation will be decided in accordance with the 
normal budgetary procedures. 
52 7.2  Itemized breakdown of cost (in ECU million) 
-DISEASES  ACTION  YEARS 
AREA 
PDB  1996  1997  1998  1999  TOTAL 
1995  '  '1995-1999 
· Indicative  Indicative programming 
break-
.down_ 
IDV/AIDSAND  Collection of  0.2  0.3  0.3  0.3  0.3  1.4 
OTHER  epidemiological 
COMMUNI- data; establishiDent · 
CABLE  of  networks 
DISEASES 
Specific prevention  2  2.2  2.3  2.4  2.6  11.5 
measures 
(vaccination, 
safety of  blood 
and blood 
products) 
Information and  0.5  0:5  0.5  0.6  0.6  2.7 
awareness-raising 
for general public 
and target groups 
Training and  1.6  1.7  1.7  1.8  1.9  8.7 
promotion of 
human resources 
IDV/PJDS  Measures for  1.3  1.3  1.4  .  1.5.  1.5  7 
children and 
young peopfe 
Health and social  1.7  1.7  1.8  1.9  2  9.1 
support and 
assistance 
Measures to  0.4  0.4  0.5  0.5  0.5  2.3 
combat 
discrimination 
OTHER  Early detection  1.3  1.3  1.4  1.4  .  1.5  6.9 
CQMII.roNI- and systematic 
CABLE  screening 
DISEASES 
TOTAL  9  9.4  9.9  10.4  10.9  49.6 
% variation 1.05 (see communication on public health) 
53 7.3  Indicative schedule of appropriations 
1995  1996  1997  1998  1999  TOTAL 
Commitment  9  9.4  9.9  10.4  10.9  49.6 
appropriations 
Payment 
appropriations 
500/o  1995  3.2  3.2 
35%  1996  4.3  4.7  9.0 
15%  1997  -1.5  3.3  5  9.8 
1998  1.4  3.4  5.2  10 
1999  1.5  3.7  5.4  10.6 
Subsequent years  1.5  5.5  7 
TOTAL  9  9.4  9.9  10.4  10.9  49.6 
8  FRAUD PREVENTION MEASURES;  RESULTS OF MEASURES TAKEN 
The grant application forms will reqUire information on the  identity and nature of potential 
beneficiaries so that their reliability can be assessed in advance. 
Fraud prevention measures (checks, intermediate reports, final report) are included in the 
agreements or contracts between the Commission and beneficiaries. The Commission will 
check reports and ensure that work has been properly carried out before intermediate and 
final paymet;Its are made. 
· In addition, spot checks are carried out by the Commission to verify how funds have been 
used. Checks have already been carried out in relation to the financial years 1991, 1992 at:J.d 
1993 and have shown their effectiveness. 
9  ELEMENTS OF.COST-EFFECTIVENESS ANALYSIS 
9.1  Specific and quantifiable objectives; target population 
The Community measures are intended to encourage: 
improved knowledge  of communicable  diseases,  including HIV infection, 
among the general public and risk groups; 
prevention  of communicable  diseases  and  HIV/AIDS  among  the  general 
· public and risk groups;  · 
guidance and advice:  professionals in the social and health fields; 
54 social and health care:  professionals in the social  and  health fields,  work 
environment,  risk  groups  (drug  abusers,  homosexuals,  prostitutes,  risk 
situations). 
9.2  Grounds for the operation 
Rational use of budget provision based on: 
(a)  . specific  application  of  the  principle  of  subsidiarity  when  identifying 
measures to be undertaken and co-financed; 
(b)  identification and selection of  projects for co-financing in the fields of  health 
education, improving knowledge among the public and certain risk groups, 
training and stimUlation of cooperation between Member States in the field 
of prevention.  These  projects  will  be selected  and  implemented,  where 
necessary,  with national  coordinating committees to be established at the 
request of Member States,  with  participation by all  those involved in the 
preventiot;t of HIV/AIDS and other communicable diseases; 
(c)  the concept of added Community value, which will continue to be realised 
through  the  coordination  oL  national  measures,  the  dissemination  of 
information and experiences, the establishment of  priorities, the extension of 
existing  European  networks,  selection  of  European  projects  and  the 
motivation and mobilisation of all involved. 
The  main  method  of implementation  for  the  programme  is  to  support 
projects carried out in Member States.  The selection ·or priority projects is 
based largely on general and intermediate objectives, and implementation of 
the measures themselves depends on the quality and reliability of projects 
submitted ·to the competent department during _the  course of the year. 
The selection criteria for projects are as follows: 
Compatibility with the objectives and conformity with at least one of the 
established objectives; 
Examination of  the "added Community value" of the projects (transnational 
participation, development of a model applicable in other Member States, 
information usable in other Member States, etc.); 
Presumed effectiveness and profitability; 
Clarity and justification of requirements; 
Population targeted or affected by the measure; 
Relevance of the selected methodology; 
Organizational competence and experience; 
Suitability of budget for objectives; 
Support for projects from national partners; 
Objective assessment; 
Opinion of the advisory committee involved. 
55 9.3  Monitoring and evaluation of the operation 
9.3.1  Monitoring of  the operation: 
Monitoring at Community level is by the Commission, which will submit an 
· annual report on the operation of  the programme to the Council, the European 
Parliament, the. Economic and Social Committee and the  Committee of the 
Regions,  and  at ·national  level  by  national  coordinating  committees,  if 
Member States choose to establish such committees, by the ministries with 
responsibility for .the prevention of  AIDS and other communicable diseases, 
NGOs and those responsible for the implementation and conduct of specific 
projects. 
9.3.2  Evaluation 
Evaluation will be by means of 
An annual report on the execution of  the programme to the Council, 
the European Parliament, the Economic and Social Committee and the 
Committee of the Regions; 
An independent evaluation of the main measures and of subsidised 
studies; 
· An  overall  report  on  the  reliability  and  effectiveness  of projects 
implemented  under  the  action  plan,  to  be  submitted  by  the 
Commission to the competent institutions during the second half of 
1997. 
Performance indicators selected for this· evaluation: 
Estimate of the target population reached and any media coverage; 
Evaluation  of  projects  by  Commission  officials  and/or  those 
cooperating with them; 
Analysis of  intermediate reports on measures scheduled and financed, 
allowing a shifting of emphasis where possible; 
Impact studies by external bodies; 
Relevance of the methodology used by organizers; 
Suitability of the budget for the objectives; 
Clarity of original objectives; 
Skills anr  ence of bodies; 
Di <>semin  vf results. 
Evaluation 1  ~ocedures and intervals: 
Drawint: up of intermediate and final reports on the various measures 
undertaken in the field; 
Development of a "standard" evaluation form for the measure, to be 
forwarded by the beneficiaries with their final reports,  and checking 
of these documents by officials either at the Commission or in  the 
field. 
56 9.'1  Coherence with financial programming 
Is  the operation incorporated in the DG's financial programming for the relevant 
years? Yes.  , 
To which broader objectives defined in the DG's financial programming does the 
objective of  the proposed operation correspond? 
"To  contribute  towards  ensuring  a  high  level  of human  health .Protection"  ~ 
Article 129 of the Treaty. 
10  AnMINISTRATIVE EXPENDITURE  (PART A  OF THE BUDGET) 
The new action  programme referred  to in this financial  statement comes 
under the new responsibilities of  the Community in the field of  public health 
following entry into force of the Maastricht Treaty (Article 129). 
In addition to the staff currently carrying out similar and preparatory work, 
implementation .of" the programme will necessitate the following additional 
staff:  one grade A official, one grade.B official and one grade C official  ~ 
subject to the outc<>me ofthe 1995  budget procedure and the Commission 
- Decision on the allocation of  funds.  This additional personnel could be made 
available either by internal deployment of staff within the Commission or as 
part of the decision on the allocation of human resources to be taken by the 
Commission in 1995.  · 
The following meetings and missions are planned for  1995  in conjunction 
with the launching and iqtplementation of the new action programme (the 
budget headings relating to meetings and missions are A 2500 and A  1300 
respectively): 
57 Meetin&s: 
2  meetings  of the  Advisory  Committee  (two  representatives  per 
Member State)  ·· 
(2 X  24 X  658 = 31  584) 
32 000 
4 meetings of experts 
(4 X 6 X 658 =  15.792) 
16 000 
Conferences and seminars for presentation and implementation 
(4 X  48 X  658 = 126 336) 
126 000 
TOTAL MEETINGS:  ECU 174 000 
Missions: 
Luxembourg-Brussels (5 missions per month) 
(60 X  200 =  12 000) 
Other missions (Member States) 
(25  x  1000 =  25 ·ooo) 
TOTAL MISSIONS:  ECU 37 000 
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